glycan_entity	frequency
N-glycans	213
N-glycosylation	100
N-glycan	82
glycosylation	73
Tn antigen	71
N-linked glycans	60
sialic acid	58
fucosylation	51
N-linked glycosylation	51
Tn	47
sialylation	44
O-glycans	43
O-glycosylation	34
Lewis X	34
MUC1	32
N-linked oligosaccharides	31
sialyl Lewis X	28
GlycA	27
Thomsen-Friedenreich antigen	26
mannose	25
M2BPGi	24
O-linked glycans	23
fucose	22
glycans	21
sialyl-Tn	21
GalNAc	20
sialylated glycans	19
fucosylated glycans	19
N-linked glycan	19
O-glycan	18
core fucosylation	18
T antigen	17
sialic acids	16
HNK-1	15
T	15
galactosylation	14
sialyl Lewis x	14
O-linked oligosaccharides	14
Lewis x	14
hyperglycosylated hCG	13
bisecting GlcNAc	13
Lewis(x)	13
N-acetyllactosamine	13
sialic acid residues	11
N-linked carbohydrates	11
sialyl-Lewis X	10
glycated albumin	10
sialyl Lewis x (sLe(x))	10
Globo H	10
N-glycan branching	10
STn	10
O-GlcNAc	10
SSEA-4	10
oligosaccharides	10
N-glycosylated	10
sialyl-Lewis x	9
N-glycopeptides	9
O-linked glycosylation	9
N-acetylgalactosamine	9
N-acetylglucosamine	9
sialoglycans	9
core fucose	8
fucosylated N-glycans	8
fructosamine	8
sialyl Le(x)	8
Le(x)	8
galactose	8
polysialic acid	8
glycan	7
glycation	7
sialyl-Tn antigen	7
sialylated N-glycans	7
Le(y)	7
GM3	7
core 2 O-glycans	7
O-GlcNAcylation	7
sialyl-Lewis(x)	7
N-acetylgalactosamine (GalNAc)	6
sialyl Lewis a	6
bisecting N-acetylglucosamine	6
α2,3-linked sialic acid	6
Lewis Y	6
LewisX	6
Sialyl Lewis X	6
glycan shield	6
sialosyl-Tn	6
galectin-3	6
pentosidine	6
sialyl-Tn (STn)	6
sialyl-Lewis a	6
sialyl Lewis(x)	6
CA19-9	6
N-linked glycosylation sites	6
glycosylphosphatidylinositol (GPI)	6
anti-laminaribioside	6
anti-chitobioside	6
anti-mannobioside	6
galectin-1	6
fucosylated glycan	5
polylactosamine	5
IgG N-glycans	5
Mac-2 binding protein glycosylation isomer	5
N-glycan structures	5
N-glycome	5
N- and O-glycans	5
high mannose glycans	5
agalactosylation	5
core fucosylated glycans	5
lactosylceramide	5
α2-6 sialylation	5
sialylated O-glycans	5
LacdiNAc	5
Lewis(X)	5
advanced glycation end products (AGEs)	5
glycosylated	5
core-fucosylation	5
asialofetuin	5
carbohydrate-deficient transferrin (CDT)	5
sialyl residues	5
carbohydrate-deficient transferrin	5
O-glycosylated	5
chondroitin sulfate	5
sialyl Lewis X (sLeX)	5
glycan-related biomarkers	5
MUC2	5
MUC1 mucin	5
2,3-sialyl T antigen, core 1-type O-glycan	5
N-glycan profile	4
core-fucosylated N-glycans	4
NA2F	4
core-fucosylated biantennary glycans	4
NGA2F	4
oligomannose	4
sulfated glycans	4
N-glycosylation site	4
Globo-H	4
glycopeptides	4
high-mannose-type glycans	4
oligosaccharide chains	4
Le(a)	4
free oligosaccharides	4
glycan moieties	4
O-linked glycopeptides	4
αGlcNAc	4
Lewis X Antigen	4
glycan structures	4
Sialyl-Tn (STn)	4
Sialyl-Le(x) (SLe(x))	4
SSEA-3	4
GlcNAc	4
glycan epitopes	4
sorbitol	4
Tn-antigen	4
complex glycans	4
glycosphingolipids	4
glucosepane	4
glycosylation site	4
complex N-glycans	4
Neu5Ac	4
reelin	4
6-sulfo sialyl Lewis X	4
aberrant glycan structures	4
N-glycolylneuraminic acid (Neu5Gc)	4
N276 glycan	4
Lewisx	4
sialyl Lewis x (sLex)	4
anti-laminarin	4
heparan sulfate	4
IgG glycosylation	3
complex-type glycans	3
afucosylation	3
high-mannose glycans	3
high-mannose N-glycans	3
Sialyl-Lewis X	3
glycosaminoglycans	3
sialyl Lewis-X	3
N- and O-linked glycans	3
N-acetylglucosamine (GlcNAc)	3
digalactosylation	3
NA2	3
high mannose N-glycans	3
tri- and tetra-antennary N-glycans	3
terminal galactosylated N-glycans	3
α2,3-linked sialylation	3
core 2-branched O-glycans	3
Fucosylated haptoglobin	3
T-antigen	3
high-mannose type N-glycans	3
GM2	3
O-glycan chains	3
GD3	3
Thomsen-Friedenreich (TF) antigen	3
Lewis(y)	3
A2BG2	3
α2,6-linked sialic acids	3
6-sulfo sialyl Lewis x	3
TF-antigen	3
sialylated structures	3
sialyl Lewis X (SLe(x))	3
Man8	3
Man9	3
Lewis x antigen	3
N-linked glycan moieties	3
core 1 O-glycans	3
Sialyl-Le(a) (SLe(a))	3
hypoglycosylation	3
trisialotransferrin	3
tetrasialotransferrin	3
pentasialotransferrin	3
bisecting N-acetylglucosamine (GlcNAc)	3
poly-N-acetyllactosamine	3
glycosylated ferritin	3
O-linked carbohydrates	3
glycosylated protein	3
Oligosaccharides	3
Sialyl-Tn	3
N-linked oligosaccharide chains	3
branched N-glycans	3
N197 glycan	3
complex-type N-glycans	3
N-linked sugars	3
GalNAc O-glycosylation	3
galactosylated glycans	3
MUC-1	3
sialyl-Lewis(a)	3
GM3 ganglioside	3
non-enzymatic glycosylation	3
core-fucosylated	3
α2,6-sialic acid	3
furosine	3
glycosylphosphatidylinositol (GPI) anchor	3
O-linked sugars	3
N- and O-linked glycosylation	3
alpha1,6-fucosylated	3
N-linked carbohydrate chains	3
N-linked glycosylation site	3
core 1-derived O-glycans	3
CD15	3
MUC1 glycopeptides	3
carbohydrate chains	3
sialyl T	3
N-linked glycan structures	3
sialyl Lewis X (sLe(x))	3
Glycosylphosphatidylinositol (GPI)	3
core 2 branched O-glycans	3
3'-sialyllactose	3
sialyl-Lewis A	3
CA 19-9 antigen	3
sialylated	3
glycoforms	3
Lewis antigens	3
glycosylated residues	3
sialoglycoproteins	3
Sialic Acid	3
sialoglycan ligands	3
Lewis X antigen	3
O-glycosylated proteins	3
PI-glycan	3
underglycosylated MUC1	3
glucosylceramide (GlcCer)	3
sulfated glycan	3
sialylated O-linked glycans	3
glycan profile	3
fucosyl residue	3
N-glycan biosynthesis	3
hCG glycoforms	3
fucoidan	3
Lacto-N-fucopentaose III (LNFPIII)	3
HNK-1 carbohydrate epitope	3
sialyl LewisX	3
glycan-phosphatidyl inositol (GPI)	3
mannan	3
α2,6-SIA	3
PIG-linked surface structures	3
hyperfucosylated	3
Gal-9	3
Galectin-1	3
6-sulfo Lewis X	2
core 2 glycans	2
FA2G2S1	2
GP1	2
GP2	2
GP6	2
GP7	2
GP5	2
bisection	2
core 2 O-glycan	2
NA3Fb	2
NA4	2
NA2FB	2
tri-antennary structures	2
α2,6-linked sialic acid	2
salivary glycopatterns	2
sialylated N-glycan	2
Thomsen-nouveau (Tn) antigen	2
NGA2FB	2
bisecting N-acetylglucosamine (GlcNAc) glycoforms	2
glycosylated PD-L1	2
oligosaccharides terminating in GlcNAc or N-acetyl-lactosamine with occasional α1,2-linked fucose	2
triantennary glycans	2
high-mannose glycan	2
GM1	2
mucin glycans	2
monogalactosylation	2
Neu5Gc	2
β1-6 branching	2
N-glycan epitopes	2
advanced glycation endproducts (AGEs)	2
paucimannosidic glycans	2
sialylated MUC1	2
trisialylated triantennary glycans	2
deglycosylation	2
core 1	2
highly fucosylated N-glycans	2
cutaneous lymphocyte-associated antigen (CLA)	2
human milk glycans	2
carbohydrate deficient transferrin	2
GalNAc-ol	2
sulfation	2
FA2B	2
A2G2	2
FA2G2	2
sialyl Lewis A	2
mannosylation	2
fucosylated glycoform	2
diantennary structures	2
sialyl Lewis-X (sLe(X))	2
sialosyl-Tn antigen	2
Fructosamine	2
complex-type N-linked glycans	2
core fucosylated structure	2
fucosylated N-linked glycans	2
fucosylated O-linked glycans	2
GalNAc residues	2
Man5	2
glycation sites	2
core 2-based O-glycans	2
serum glycans	2
fucosylated	2
Glycosylation	2
truncated O-glycans	2
N-linked glycopeptides	2
alpha2,6-sialylation	2
specific glycan structures	2
terminal sialic acid	2
Mac-2 binding protein glycosylation isomer (M2BPGi)	2
Lewis X pentasaccharide	2
core 2	2
sialyl-Le(x)	2
Carbohydrates	2
sulfated Lewis X	2
fucosylated epitopes	2
Tn (GalNAc)	2
STn (sialyl alpha2-6 GalNAc)	2
TF (Gal beta1-3 GalNAc)	2
NeuAc-Gal-GlcNAc2	2
Tn antigen (α-O-GalNAc-Ser/Thr)	2
IgG galactosylation	2
mucin-type O-glycans	2
mannose type glycans	2
O-glycosylations	2
Lewis X (LeX)	2
E-selectin ligand	2
N276-glycan	2
sialyl-Tn (sTn)	2
trifucosylated tetra-antennary glycan	2
nonglycosylated prostate-specific antigen (PSA)	2
NG1(6)A2F	2
advanced glycation end products	2
alpha-galactosylceramide	2
IgG sialylation	2
Sialyl-Tn antigen	2
sialyl-core 1 structure (NeuAcα2-3galactosyl β1-3-N-acetylgalactosamine)	2
sialylated hybrid structures	2
N-glycan chains	2
Peak3	2
glycated hemoglobin	2
hyperglycosylated human chorionic gonadotropin	2
N-glycosylations	2
high mannose	2
Tn antigen (GalNAcα1-Ser/Thr)	2
mannosylated	2
asparagine-linked glycans	2
core and outer arm fucosylation	2
sialic acid (Sia)	2
underglycosylated mucin	2
outer arm to core fucose	2
tetrasialylated structures	2
mannose structures	2
sialyl Lex	2
O-linked carbohydrate	2
glycosylation sites	2
Advanced glycosylation end products (AGEs)	2
glycosylated serum albumin	2
alpha-1-acid glycoprotein	2
hypoglycosylated MUC1	2
Lewis(b)	2
Fucosylated glycans	2
highly sialylated multi-branched glycans	2
oncofetal fibronectin	2
highly-branched	2
α2,3-linked sialic acids	2
core-2 O-glycans	2
complex-type oligosaccharides	2
glycosyl phosphatidylinositol (GPI)	2
high branching (HB)	2
triantennary (TRIA)	2
GM1 ganglioside	2
N-acetyl-galactosamine	2
cancer-associated glycan alteration	2
glycan nodes	2
N-linked carbohydrate	2
Le(X)	2
N-linked and O-linked carbohydrates	2
fucosylated glycoforms	2
AC133	2
N-glycosylated clusterin	2
alpha GalNAc	2
fructosyl-lysine	2
GalNAcalpha-O-bn	2
O-linked β-N-acetylglucosamine (O-GlcNAc)	2
glycan features	2
glycan motifs	2
N-glycosylated peptides	2
α2,6-sialylated N-glycans	2
D-mannosyl residues	2
Sialyl Lewis X Antigen	2
α2,6 sialylation	2
Lewis type 1 antigens	2
trisialylated triantennary glycan	2
6-sulfo-sialyl Lewis x	2
CD45RB glycosylation	2
glycosylphosphatidylinositol	2
Glycated albumin	2
sialyltransferases	2
aberrant glycans	2
core2 O-glycans	2
Lewis x (Le(x))	2
MUC4	2
alpha (1)-acid glycoprotein (AGP)	2
sialosyl-Le(x)	2
aglycosylated	2
asparagine-linked glycosylation	2
Tf-Gly	2
sialylated tumor-related antigen (sTRA)	2
GlycB	2
Asn-linked glycosylation	2
glycosylated G-CSF	2
complex-glycosylated	2
α2,3-sialic acid	2
glucose monomycolate	2
N-glycosylation variants	2
glycophospholipid	2
α2,3-sialylation	2
MUC16	2
sialyl Le(a)	2
carbohydrate moiety	2
sialyl-Lewisx epitopes (sLe(x))	2
glycosylation pattern	2
IgG fucosylation	2
glycan adducts	2
fucosylated N/O-glycans	2
biantennary glycan	2
sialyl 6-sulfo Lewis X	2
Man9GlcNAc2	2
dextran sulfate	2
α1,4-linked N-acetylglucosamine (αGlcNAc)	2
HNK-1 glycan	2
glycan moiety	2
sLe(x)	2
asparagine-linked oligosaccharides	2
mucin-type glycans	2
sialyl-Lewisa	2
sialyl-Lewisx	2
CCA-associated carbohydrate antigen (CCA-CA)	2
advanced glycation endproducts	2
4-O-hexosaminyl-containing disaccharide mimics	2
lactose	2
glycan composition	2
core 3 O-glycan	2
6-sulfo N-acetyllactosamine	2
sialylated epitope	2
carbohydrate residues	2
O-glycosylated peptides	2
sTRA	2
bifucosylated tetra-antennary glycan	2
Lewis A	2
advanced glycation end-products (AGEs)	2
TA-MUC1	2
TF	2
L2/HNK-1 carbohydrate epitope	2
Amadori albumin	2
high mannose type glycan	2
under-glycosylated MUC1	2
glycosyl-phosphatidylinositol (GPI)	2
mannoproteins	2
SLe(x)	2
LacNAc	2
Gd-IgA1	2
sialyl lewis A	2
oligomannose N-glycans	2
Man5GlcNAc2	2
anti-glycan antibodies	2
α1,4-linked N-acetylglucosamine	2
N-glycosylation patterns	2
Mucin-1	2
PMM2-CDG	2
Polysaccharides	2
MUC5AC	2
alpha-N-acetylgalactosamine (GalNAc)	2
glycosylated forms	2
Galactose-deficient IgA1	2
anti-Saccharomyces cerevisiae antibodies (ASCA)	2
N332 glycan	2
sialyl T antigen	2
O-glycopeptides	2
high-mannose glycosylation	2
CA50	2
sialyl Lewis A (sLe(a))	2
tumor-specific glycan changes	2
sialyl-TN glycans	2
gp120	2
sulfo-Lewis(a)	2
fucosylated glycoforms of IgG2	2
deglycosylated ricin A chain	2
Thomsen-Friedenreich	2
N-Glycan	2
N-glycan modifications	2
sialic acid-containing glycans	2
truncated O-linked saccharides	2
fucosylated PSA	2
Tn antigens	2
phosphatidylinositol-glycan (PI-G)	2
N-glycolylneuraminic acid	2
N-acetylneuraminic acid (Neu5Ac)	2
α-Gal	2
phosphatidylinositol-glycan	2
oligomannoside	2
Heparan sulfate	2
Lewis(Y)	2
Hyperglycosylated hCG	2
Hyperglycosylated hCGβ	2
fucosylated triantennary sugar chain	2
mucin O-glycans	2
ACCA	2
embryoglycan	2
HNK-1 carbohydrate	2
Galbeta1-4GlcNAc	2
sialyl residue	2
anti-Saccharomyces cerevisiae	2
branched glycans	2
glycated Lp(a)	2
galactose-deficient immunoglobulin A1 (Gd-IgA1)	2
CA 19-9	2
sialic acid alpha2-3 galactose linkage	2
Galbeta1-3GalNAc	2
N- and O-linked glycan residues	2
N-glycan structure	2
anti-chitin	2
α2,6-sialylation	2
NeuAc alpha 2-3Gal	2
core-1 O-glycans	2
orosomucoid	2
HNK-1 epitope	2
α2-6-sialic acid	2
6'-sulfated sialyl Lewis X	2
N-glycopeptide IgG2-GP09	2
sialyl-Lewis-X	2
heparin	2
heavy chain glycans	2
Alpha-L-fucose	2
anti-chitine	2
sialyl Lewis(x) (sLe(x))	2
polylactosaminoglycans	2
sialyl-di-Lewis a	2
sialylated glycan-structures	2
carbohydrate moieties	2
glycan branching	2
hyposialylation	2
mannosides	2
glycocalyx	2
sialyl-Tn (sTn) antigen	2
agalactosylated (G0) IgG	2
V3-glycan	2
polylactosaminoglycan	2
Asn-linked oligosaccharides	2
hyaluronan	2
GalNAcbeta1-4(Fucalpha1-2Fucalpha1-3)GlcNAc (LDN-DF)	2
hyaluronic acids	2
N-acetyl glucosamine residues	2
N-acetyl methyl groups	2
core-fucosylated haptoglobin	2
Wisteria floribunda agglutinin positive Mac-2-binding protein (M2BPGi)	2
α2,6 sialylated N-glycans	1
digalactosylated monosialylated biantennary with core and antennary fucose	1
the ratio of all fucosylated monosialylated and disialylated structures	1
the proportion of high mannose glycan structures in total neutral IgG glycans	1
the percentage of all fucosylated structures in total neutral IgG glycans	1
the incidence of bisecting GlcNAc in all fucosylated digalactosylated structures in total neutral IgG glycans	1
difucosylated Lewis Y (LeY)	1
α-GalNAc Tn-antigen	1
Core 1 and Core 2 glycan structures	1
Fuc1Hex5HexNAc5	1
IgG1 glycosylation traits	1
fucosylation on IgG1, IgG2 and IgG3	1
glycosylation of mucin 1	1
glycosylation of mucin 16	1
glycosylation of CD63	1
undersialylated and undergalactosylated biantennary and triantennary glycans	1
aglycosylated glycoform	1
mono-sialylated glycoform	1
glycan compositions or/and structures	1
α-2,6 sialic acid	1
sialyllactose	1
lactose- and N-acetyllactosamine (LacNAc) type-II-core glycans	1
NeuAcα2-3Galβ1-4(+/-Fucα1-3) Xylα1-3Glc	1
Core 1/Core 3 O-glycosylation	1
α-2,3 sialylation	1
α-1,2 fucosylation	1
core 1 sialylated O-glycans	1
Lewis-X antigen (Lex, CD15) (Galβ1-4(Fucα1-3)GlcNAcβ1-R)	1
G2	1
FA2BG1	1
T-antigen (Galβ1-3GalNAc)	1
Fc-bisection	1
Fc-sialylation	1
Fc-fucosylation	1
O-acetylated sialoglycans	1
oligomannose N-glycan	1
IgG Fc N-glycan traits	1
galactose and sialic acid structures	1
GP4	1
GP24	1
GP9	1
GP13	1
GP15	1
GP18	1
GP23	1
Hex1	1
HexNAc1Hex1Neu5Ac1	1
digalactosylated (G2)	1
agalactosylated (G0)	1
fucosylation (F)	1
bisected N-acetylglucosamine	1
complex β1-6 branched N-linked oligosaccharides	1
N-glycosylation signatures	1
stage-specific embryonic antigen 4 (SSEA-4)	1
GP14	1
sialyl-Lewis antigen	1
fucosylated haptoglobin	1
Mac-2 bp glycosylation isomer	1
Glucosylsphingosine	1
paucimannosidic N-glycans	1
complex N- and O-glycans	1
isomeric N-glycans	1
O-mannose-bound matriglycan	1
N-glycans carrying bisecting N-acetylglucosamine	1
N-linked glycan compositions	1
GlcNAc bisection	1
H5N2	1
H6N2	1
H7N2	1
H3N3F1	1
H5N5F1	1
Globo H hexasaccharide	1
bifucosylated triantennary N-glycan (peak10, NA3F2)	1
N-glycan structures (peak9, NA3Fb)	1
N-glycan structures (peak12, NA4Fb)	1
disialyl core 1 O-glycan	1
tri-antennary and sialylated N-glycans	1
core-fucosylated glycans	1
bisected glycans	1
agalactosylated, HexNAc terminated IgG1 glycoforms	1
bisecting glycoforms	1
biantennary glycoforms	1
tetra-antennary α-2,3 sialylated N-glycans	1
dimeric Le(x)	1
galactosylated N-glycans	1
Lewis-X	1
N58 glycan	1
nonsialylated, nonfucosylated N-glycans	1
fOSs	1
pauci-mannose	1
HexNAc4 Hex5 Fuc1 NeuAc1	1
HexNAc4 Hex5 Fuc1 NeuAc2	1
6-sulfo type2 lactosamine	1
6-sulfo Lewis Y	1
3'-sulfo type1 lactosamine	1
3'-sulfo Lewis A	1
Cervical glycans	1
Cervical glycome	1
NeuAcα2-3Galβ1-3N-acetylgalactosamine (GalNAc)	1
sialyl Lewis X antigen	1
trisialylated monofucosylated triantennary glycan (A3F)	1
extended O-glycans	1
Galbeta(1-3)GalNAc	1
H3N5	1
H4N3F1P1	1
H5N4F1P1	1
S1H5N4F1	1
NA4Fb	1
NG1A2F	1
dimLea	1
LebLea	1
bigalacto core-α-1,6-fucosylated biantennary glycan	1
branching α-1,3-fucosylated triantennary glycan	1
terminal lactosamine	1
α1,6 and α1,3 fucosylated oligosaccharides	1
GalNAcα1,3(LFucα1,2)Galβ1,3/4GlcNAcβ1	1
chitotriose	1
α1,2-linked fucose	1
α2,6 sialic acids	1
Thomson-nouveau antigen (Tn)	1
sialylated form (STn)	1
oligo-mannose	1
hybrid-type	1
α2,6-sialylated structures	1
tetra-antennary structures	1
glycomic fingerprint	1
core-fucosylated triantennary glycans with outer-arm fucose	1
high mannosylated glycans	1
bisected type N-glycans	1
LewisX antigens	1
complex type N-glycans with bisecting GlcNAc	1
sTn antigen	1
Tn antigen (GalNAcα1-Thr/Ser)	1
GAG-NREs	1
immature truncated O-glycans	1
high mannose, core-fucosylated, hyperbranched/hypersialylated N-glycans	1
glycan (m/z 2118)	1
O-glycosylated MUC1	1
N-glycan profiles	1
Glc₁Man₉GlcNAc₂	1
Gal₂Man₃GlcNac₄Fuc₁Neu₁	1
Man₄GlcNac₂	1
Gal₂Man₃GlcNac₄Neu₃OAc₃	1
Man₃GlcNac₅ Fuc₁	1
Glycan	1
O-linked N-acetylgalactosamine (O-GalNAc)	1
core fucosylated glycoforms	1
sialyl-Lewis x -Lewis x	1
O-linked glycans carrying alpha2,3-linked sialic acid	1
Mac-2 Binding Protein Glycosylation Isomer	1
asialylated or monosialylated biantennary and triantennary N-glycans	1
fully galactosylated structures	1
bisialylated biantennary and trisialylated triantennary structures	1
agalacto core-alpha-1,6-fucosylated biantennary glycan (NGA2F)	1
Lewis(X) motif	1
tetraantennary N-glycans	1
core-fucosylated biantennary digalactosylated N-glycan	1
tri- and tetra-antennary fucosylated N-glycans	1
IgG1G0F	1
IgG2G0F	1
IgG2G1FN	1
IgG2G1FS	1
IgG2G2S	1
IgG4G0F	1
IgG4G1FS	1
IgG4G1S	1
IgG4G2FS	1
IgG4G2N	1
mannose-enriched glycans	1
Sia-alpha2-6Gal/GalNAc	1
monosialylated glycans	1
NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-2Manalpha1-3Manbeta1-4GlcNAc	1
glycan chains of fetuin	1
Core 1-derived O-glycans	1
Core 2-derived O-glycans	1
Core 3-derived O-glycans	1
monofucosylated N-glycans	1
difucosylated N-glycans	1
core-type fucosylated N-glycan	1
Lewis-type fucosylated N-glycan	1
NeuAc1Gal1GalNAc1	1
NeuAc2Gal1GalNAc1	1
monosialylated diantennary glycans A2G2S(6)1 and FA2G2S(3)1	1
α2,3 sialylation	1
complex glycan	1
N-Glycans	1
GD1	1
sialyl-T (O-glycan)	1
free oligosaccharides (fOSs)	1
core-2 tetrasaccharide Galbeta1-->4GlcNAcbeta1-->6(Galbeta1-->3)GalNAcOH++	1
sialyl Lewis x antigen	1
disialylated, monofucosylated glycan	1
monosialylated, trifucosylated glycan	1
core fucose residues	1
core-fucose	1
complex neutral	1
fucosyltransferases	1
glycosylation level	1
total α-1,6-core fucosylated biantennaries (NGA2F, NG1A2F, NA2F)	1
total bisecting α-1,6-core fucosylated biantennaries (NGA2FB, NA2FB)	1
branching α-1,3-fucosylated triantennary N-glycan (NA3FB)	1
α-1,6-core fucosylated structure NA2F	1
non-fucosylated structure NA2	1
pauci-mannose/mono-antennary type N-glycans	1
bisecting GlcNAc residues	1
(neo)lacto-series glycosphingolipids	1
2-linked mannose	1
β1-4 branching	1
4-linked GlcNAc	1
antennary fucosylation	1
fucosylated triantennary structures	1
fucosylated biantennary with core-branched N-acetylglucosamine	1
triantennary structures	1
tetraantennary tetrasialylated glycan with a polylactosamine extension, A4G4LacS4	1
triantennary trisialylated glycan containing the SLex epitope	1
bisecting and sialylated glycans	1
Core 1 type glycans	1
core-fucosylated, multiply branched and sialylated structures	1
two core-fucosylated and agalactosylated glycans (m/z 1591, 1794)	1
sialyl (S)Tn	1
glycated hemoglobin HbA1c	1
PGP10(FA1G1Ga1)	1
PGP11(FA2G2)	1
PGP15(FA3G2)	1
PGP17(A2G2S)	1
BGP11(F(6)A2B)	1
sialylated tri- or tetra-antennary glycans	1
3-sialylated tri-antennary N-glycopeptides	1
sialylated Lewis type epitope	1
core-fucosylated high mannose N-glycans	1
internally sialylated glycans	1
Sialyl Lewis X (sLe<sup>x</sup>)	1
DSIgG1 G1FN/G0FN, G2N/G2, G2FN/G2N	1
DSIgG2 G1F/G0F, G1FN/G0FN, G2N/G1N, G2S/G2	1
agalactosylated biantennary glycans	1
biantennary (NA2) N-glycans	1
triantennary (NA3) N-glycans	1
bisected complex type N-glycans	1
H4N3S1	1
H4N3F1	1
H6N4S2	1
H6H5F1S2	1
H6N5	1
H6N6F1S1	1
O-linked galactosyl beta1,3 N-acetylgalactosamine (Gal beta1-->3GalNAc)	1
α1-6 fucosylated tri-antennary glycans	1
core- and arm-fucosylation on tetra-antennary glycans	1
high-mannose type glycans	1
highly-branched sialyted N-glycans	1
Bisecting GlcNAc	1
triantennary glycan	1
sialylated mucin-type O-glycan with core 1- and core 2-based structures	1
H-type 1 antigen (Fuc-α1,2-Gal-β1,3-GlcNAc)	1
sialylated glycan chains	1
sulfated O-glycans	1
poly-N-acetyllactosamine chains	1
complex-type branched N-glycans	1
outer-arm fucosylation	1
tri- and tetra-branched structures	1
bisecting glycans	1
N-linked glycome	1
sialyl Lewis antigens	1
core-fucosylated-agalacto-biantennary	1
fucosylated-galactosylated-triantennary	1
afucosylated-galactosylated-biantennary	1
multi-glycans	1
methylglyoxal	1
sialyl-Lewis X (SLe(X))	1
bisected N-glycans	1
di/triantennary complex type N-glycans	1
biantennary fucosylated structures	1
fucosylated, afucosylated tri- and tetraantennary structures	1
N-glycans H6N5F1	1
N-glycans H7N6F1	1
N-glycans H3N4F1	1
N-glycans H5N4F3	1
core 2-based glycans	1
core 1-based glycans	1
6-sulfo sialyl Lewis x (sLex)	1
MECA-79 epitope	1
NeuAcalpha2-3Galbeta1-3GalNAc-ol	1
Galbeta1-3GalNAc-ol	1
NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6[NeuAcalpha2-3Galbeta1-3]GalNAc-ol	1
NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6[NeuAcalpha2-3Galbeta1-4GlcNAcbet a1-3Galbeta1-3]GalNAc-ol	1
acetylation	1
globo-type glycans	1
disialyl gangliosides	1
glycan biomarkers	1
known glycan structures	1
A2G1	1
FA2[6]G1	1
FA2[3]G1	1
FA2[6]BG1	1
FA2[3]BG1	1
FA2G2S2	1
Hex4HexNAc2	1
Hex7HexNAc6dHex1Neu5Ac4	1
biantennary complex-type N-glycan	1
high-mannose structures (Hex(5-9)HexNAc(2))	1
complex/hybrid-type glycans (NeuAc(0-3)Fuc(0-3)Hex(3-8)HexNAc(3-7))	1
bisecting N-linked glycan structures	1
Mac-2 binding protein glycosylation-modified isomer (M2BPGi)	1
gangliosides	1
polysialylated glycans	1
HNK1-epitope	1
6-sialylated biantennary glycans	1
oxidation	1
O-acetylated sialoglycoproteins	1
sialylated N-glycan structures	1
fucosylated N-glycan structures	1
tandem repeat polypeptides	1
sialylated bi-antennary glycans	1
tri-antennary, N-linked, fucosylated glycans	1
minor tri-antennary N-linked glycan	1
O-mannosylated glycan	1
cell surface glycosylation	1
sialyl Lewis X epitopes (SLe(X))	1
core fucosylated agalactosyl biantennary glycans	1
core glycan, consisting of two GlcNAc and three hexoses	1
3'-sialyl N-acetyllactosamine (3'-SLN)	1
glycan repertoire of the human parasite Schistosoma mansoni	1
DTR motif of MUC1	1
α2,3-linked sialoglycans	1
α2,6- and α2,3-sialylated glycan structures	1
GalNAc-Ser/Thr	1
fucosyl vs non-fucosyl	1
O-linked glycan	1
mucin core-1 sugar	1
biantennary complex type disialyloligosaccharide	1
Oligomannosidic glycans	1
(2,6)-branched triantennary glycans	1
hybrid structures	1
alpha(1,3)-fucosylation	1
alpha(1,6)-core fucosylation	1
bisecting GlcNAc residue	1
di-sialylated T-antigen (NeuAcα2,3Galβ1,3(NeuAcα2,6)GalNAc)	1
mannose octasaccharide	1
mannose hexasaccharide	1
biantennary complex-type structure	1
core-2 glycans	1
CA 125	1
oligomannose glycoforms	1
GalNAc alpha 1----Ser/Thr	1
alpha2,3-sialylation	1
WFA-recognized glycans	1
terminal N-acetyl galactosamine	1
N-acetyl glucosamine oligomers	1
tri/tetra-antennate non-bisected complex N-linked glycan	1
core fucosylated, agalactosyl biantennary glycans (FA2)	1
sialyl Lewis x (SLe(x))	1
non-natural sialyl TF-beta O-glycan	1
high-mannose N-glycan [-(N-acetylglucosamine)2-(mannose)5-8]	1
high-mannose and fucosylated biantennary complex N-linked glycans	1
type-2 oligosaccharides	1
alpha2-3 sialylation	1
bisecting N-acetylglucosamine residue	1
neutral oligosaccharides	1
alpha1,6-fucosylation	1
Core 1 (beta-Gal(1-3) alpha-GalNAc-O-Ser/Thr)	1
S-linked glycans	1
Lewis(X) antigen	1
TIMP-1 glycans	1
biantennary and hybrid N-linked structures	1
high mannose N-glycan	1
Siaα2,6Gal	1
Siaα2,3Gal	1
glycoforms of fetuin	1
N- and O-linked sugars	1
non-sialylated N-glycans	1
GlcNAc(2)Man(7)	1
sialylated T-antigens	1
highly sialylated O-linked glycans	1
Le(a) trisaccharide antigen	1
Le(x) trisaccharide antigen	1
DF3 epitope	1
alpha 1-ACT glycans	1
terminal glycosylation	1
FA2BG2	1
Lewis(x) epitope	1
high-mannose 5	1
tetraantennary structures	1
core-fucosylated tetraantennary N-glycans	1
advanced glycation end product (AGE)-modified proteins	1
asparagine-linked saccharide units	1
monoantennary glycans	1
highly sialylated glycans	1
disialylated glycans	1
tri- and tetra-antennary glycans	1
tri-, di-, mono- and non-sialylated complex-type N-glycans	1
bi-antennary-fucosylated GlcNAc-terminated residues	1
Wisteria floribunda agglutinin reactive glycan (LacdiNAc)	1
Lewis X antigen group	1
O-glycan cryptic epitope, gp(C1)	1
Muc1	1
core-fucosylated bi-antennary monosialylated glycans	1
bisecting bi-antennary and non-fucosylated glycans	1
sialylated N-glycopeptide structures LPTQNITFQTESSVAEQEAEFQSPK HexNAc6, Hex3, Neu5Ac2	1
structure IVLDPSGSMNIYLVLDGSDSIGASNFTGAK HexNAc5, Hex4, Fuc1	1
Le(a)Le(x) tumor-associated carbohydrate antigen	1
L-galactosylated dimeric sialyl Lewis X	1
O-mannosyl glycans	1
sialic acid-containing structures	1
fucose-containing structures	1
α1,3fucosylated AGP (fAGP)	1
glycans with one complex type antenna	1
bigalactosylated biantennary glycans	1
nongalactosylated biantennary glycans	1
agalactosylated IgGs terminating with N-acetylglucosamine	1
sialylated, mucin-like domain	1
high mannose type and biantennary glycans	1
triantennary chains	1
acute-phase glycoproteins	1
O-mannose-linked HNK-1	1
core-type 1 O-glycans	1
α1,3fucosylated glycans	1
nonfucosylated glycans	1
isomers with more α-2,6-linked sialic acids	1
complex-type N-glycosylation	1
asialo-bisecting GlcNAc type N-glycan	1
Sialyl Lewis (sLe(x))	1
glycosylation of acetylcholinesterase	1
H-type II blood group determinant pentasaccharide	1
lacto-N-fucoheptaose	1
α1-3/4 fucosyl epitope at Asn 241	1
Advanced glycation end products (AGEs)	1
Fucose	1
Sialylation	1
difucosylated cores	1
paucimannosidic N-glycan (Man(3)GlcNAc(2))	1
galactosylation of diantennary glycans	1
sialylated biantennary, triantennary and tetra-antennary oligosaccharides	1
hyposialylated transferrin	1
sialylated moieties	1
mannosylated moieties	1
deoxyfructosyl-lysine	1
core type 1 and type 2 glycans	1
high mannose and complex bisecting type N-linked glycans	1
G2890	1
G3560	1
core 1 O-glycan	1
ABO blood group antigens	1
A9 antigen	1
multi-antennary glycans	1
transferrin glycans	1
Mac-2-binding protein glycosylation isomer	1
globotriaose	1
isoglobotriaose	1
α-lactosylceramide	1
Siaα2-6Gal/GalNAc	1
Galβ4GlcNAc	1
GalNAcα3GalNAc	1
Galβ3GalNAc	1
branching/LacNAc elongation	1
sialyl-T	1
N- and O-glycosylation patterns	1
MUC1 glycosylation	1
dimeric Le(x) oligosaccharide	1
glycopeptide neoantigen epitopes centering the GSTA sequence	1
glycoconjugates	1
mucin-type core 1 structures	1
core 2 O-linked sLe(x)	1
glycan modifications	1
NeuNAc alpha 2----3Gal beta 1----3 (NeuNAc alpha 2----3Gal beta 1----4GlcNAc beta 1----6) GalNAcOH	1
301N-glycan	1
O-glycan α-2,6-sialylation	1
Fucosylated structures	1
O-glycan patterns	1
sialyl-TF	1
sialyl-dimeric Le(x)	1
core-part of glycans	1
FA2	1
sugar moiety	1
Gb3	1
sulfated type 2 tumor-associated carbohydrate antigens	1
glycosylated form of Siglec-6	1
AcPAPGS(alpha GalNAc)T(alpha GalNAc)APPA	1
AcS(alpha GalNAc)T(alpha GalNAc)APPA	1
HbA1c	1
glycosylated signaling molecules	1
carboxyethyl-lysine (CEL)	1
2-succinocystein (2SC)	1
sialyl LewisX (sLex)	1
asialotransferrin to sialotransferrin ratio	1
bi-antennary structures	1
tri-antennary/bisecting structures	1
sulfated N-glycans	1
sialylated Thomsen-Friedenreich antigens	1
non-sulfated HNK-1 glyco-epitope	1
high-mannose and complex-type fucosylated N-glycans	1
serum fucosylation	1
IgG peak 7	1
PNA-specific glycans	1
truncated precursor glycan structures	1
oligo-mannose oligosaccharides	1
sialylated biantennary glycans	1
core fucosylated biantennary glycans	1
triantennary glycan with two fucoses	1
disialotransferrin	1
glycosyl modification	1
High-mannose-type, complex-type, and hybrid-type oligosaccharides	1
Man6P (mannose 6-phosphate)	1
Uridine Diphosphate N-acetylglucosamine	1
Glucosamine	1
glycated RBP	1
tumor-associated glycoprotein (TAG)-72	1
glycosylated proteoforms	1
Uridine diphosphate N-acetylglucosamine (UDP-GlcNAc)	1
biantennary N-linked	1
N-glycan core-afucosylation	1
NeuAcalpha2-3Galbeta1-3GalNAcol	1
NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcol	1
Galbeta1-3(NeuAcalpha2-6)GalNAcol	1
Galbeta1-3GalNAcol	1
N-glycan oligosaccharides	1
fucosylated paucimannose	1
GalNAc-rich O-glycans	1
N-linked complex type	1
high mannose-type N-linked glycans	1
additional glycan at the N-terminal base of the V2 loop	1
glycosylation profiles	1
monosaccharides	1
underglycosylated mucin-1 (uMUC1)	1
mucin-type glycopeptides	1
N-glycans of the oligomannosidic or hybrid type	1
HexNAc5Hex4dHex1s/p1	1
VVL	1
DSA	1
SNA	1
C-glycosyl amino acids	1
3,4,6-tri-O-acetyl-2-azido-2-deoxy-alpha-D-galactopyranosyl	1
Tn-antigenic structures	1
hyperglycosylation of CD19	1
core 2 oligosaccharide Galβ3(Galβ3/4GlcNAcβ6)GalNAc-ol	1
glycated hemoglobin (HbA1c)	1
H-type 2	1
sialyl-oligosaccharide	1
glycosylated exoPD-L1	1
advanced glycosylation end products (AGEs)	1
sialyl-Lewis(x) antigen	1
GSH	1
4-HNE	1
hCGα glycoforms	1
hCGβ glycoforms	1
aberrant glycosylated IgA1	1
N-glycosylated carbohydrate portion of 6 kDa	1
K13	1
mucin tandem repeat (TR) peptide	1
alpha-N-acetylgalactosamine-bearing glycans	1
Galbeta1-3GalNAc (core 1)	1
mono- and di-sialylated core 1	1
sialyl Tn (STn)	1
sialyl Lewis A (CA19-9)	1
sialyl Lewis C (SLeC)	1
sialyl LeX (SLeX)	1
Hyperglycosylated hCG (H-hCG)	1
sialyl-3T antigen	1
sialic acid-containing carbohydrates	1
glycophosphatidylinositol	1
sialylpolylactosamine	1
sialyl Le(x)/Le(a)	1
T antigens	1
core 1 (T)	1
salivary protein glycosylation	1
N-linked carbohydrate structure	1
fucosylated haptoglobin (Fuc-Hpt)	1
core fucosylated neutral glycans	1
N-linked mannose-5 glycans	1
xylose-containing plant complex N-linked glycans	1
galactal	1
2-nitroglycal	1
Tn (GalNAcalpha1-O-Ser/Thr)	1
Fucosylated N-glycans	1
Acetylgalactosamine	1
glycan part of serum prostate specific antigen (PSA)	1
di-sialylated glycans (sialic acid attached to sialic acid)	1
branched fucosylated galactose with N-acetylglucosamine moieties (HexNAc-(Fuc)Gal-GlcNAc)	1
NG1(3)A2F	1
PSA	1
HNK1	1
α2,3-linked sialyl N-glycan	1
N-linked intact glycopeptides	1
Tn (GalNAc-O-Ser/Thr)	1
LCA-binding fraction	1
sialyl-Tn antigens	1
core 3 structure (GlcNAcβ1-3GalNAcα1-O-Ser/Thr)	1
sLea	1
precursors of lipoxidation end products	1
alpha-galactosylsphingosine	1
Mucins	1
HexNAc2Hex5	1
HexNAc4Hex5Fuc1NeuAc1	1
HexNAc4Hex5Fuc1NeuAc2	1
N-Acetylgalactosamine (GalNAc)	1
Carbohydrate-deficient transferrin (CDT)	1
AChE glycosylation pattern	1
O-glycan T antigen	1
core-2	1
Asn332 glycan-dependent epitope	1
Asn392	1
Asn386	1
NaSO3-3GlcA(beta 1-->3)Gal(beta 1-->4)GlcNAc(beta 1-->3)Gal(beta 1-->4)Glc beta-OPr	1
oncofetal antigens	1
terminal galactose/N-acetylgalactosamine (Gal/GalNAc)	1
underglycosylated mucin-1 antigen (uMUC-1)	1
diantennary glycan	1
Sialyl Lewisx (SLeX)	1
α-1,6-fucosylation	1
Thomsen-Friedenreich antigen (TF-antigen)	1
β64N glycoforms	1
core2 O-glycan	1
core3 O-glycan	1
differential glycosylation patterns	1
sialoglycans CDw75 and HB-6	1
N-linked glycan residue	1
core-fucosylation of neutral glycans	1
core-fucosylation of sialylated glycans	1
core-1 mucin-type O-glycans	1
glycan variant	1
N-glycosylated subunits	1
N-linked GlcNAc	1
triantennary glycan-containing outer arm (alpha-1,3) fucosylation	1
core (alpha-1,6) fucosylation	1
high-mannose type (Man(4) to Man(9))	1
triantennary complex type	1
disialylated diantennary glycans	1
O-glycosylated tandem repeat domain of MUC1	1
sialylated oligosaccharide chains	1
fatty acid unsaturation	1
hyperglycosylated human chorionic gonadotrophin (hCG-H)	1
N- and O-linked glycoproteins	1
N-acetyl-d-lactosamine	1
albumin glycation	1
complex O-glycan branching	1
β4-galactosylation of highly branched N-glycans	1
core fucosylated, bisecting and sialylated modifications	1
Peak7	1
N-acetyllactosamine-containing glycans	1
high-mannose-type	1
glycosylated NELL1	1
glucosylated free oligosaccharides	1
glycosylation products	1
glycosylated IgG	1
sialyl-trimeric-Lewis x	1
advanced glycation end product	1
AGE-damaged enzymes	1
sugars	1
high mannose immature glycoprotein	1
sparsely-glycosylated MUC1	1
heavily-glycosylated MUC1	1
alpha-N-acetylgalactosamine	1
glycan synthesis	1
high-mannose type	1
core-fucosylated tetraantennary structures	1
LacdiNAc motif	1
under-galactosylated IgA1	1
neutral and sialylated glycans	1
mAb glycan profile	1
haptoglobin	1
transferrin	1
N-linked glycosites	1
O-linked β-N-acetylglucoside (O-GlcNAc)	1
altered glycosylation	1
FA2/[FA2G1 + FA2G2]-IgG1	1
m/z 1955	1
m/z 2032	1
m/z 2584	1
α-2,6 sialylated galactosides	1
N-linked oligosaccharide side chains	1
high-mannose immature CEA	1
Con-A band 2 (AFP-C2)	1
LCA-A band 1 (AFP-L1)	1
E-PHA band 2 (AFP-P2)	1
glycosylation signatures	1
Galbeta1-3GalNAcalpha	1
S-(β-D-glucopyranosyl)-D-cysteine	1
S-(2-acetamido-2-deoxy-α-D-galactopyranosyl)-L-cysteine	1
fucose (Fuc)	1
sialyl Lewis X (sLe(X))	1
α-2,6-linked sialic acids	1
alpha-L-Fuc residues	1
alpha-Man, GlcNAc(beta1,4,GlcNAc)1,2, GalNAc alpha1,3GalNAc, alpha-GalNAc, and a-Gal residues	1
Gly-Trp-Ser-Tyr-Gly	1
2,6-branched mannose	1
oligosaccharide	1
alpha-Fetoproteins	1
high mannose oligosaccharide structures	1
sialyl LacNAc	1
defucosylated N-glycan	1
terminal galactose residues	1
poly-N-acetyllactosaminyl O-glycans	1
α1-3 fucosylated glycoforms	1
Lewis X-carrying N-glycans	1
O-sialoglycoproteins	1
sialyl Lea	1
Sialyl Tn	1
H-type-1 antigen (Fucalpha1-2Galbeta1-3GlcNAcbeta1-)	1
NeuNAcalpha2-3Galbeta1-	1
highly glycosylated antigen	1
core and antenna fucosylation	1
total glycosylation	1
HMFG1	1
214D4	1
oligosaccharide moiety	1
glycosylated VDBP	1
PNA-reactive sites	1
glycan-related networks	1
3-O-SO3Na-beta-Gal-(1-->4)-beta-GlcNAc-(1-->3)-beta-Gal-(1-->4)-GlcNAc-beta-OBn	1
3-O-SO3Na-beta-Gal-(1-->3)-beta-GlcNAc-(1-->3)-beta-Gal-(1-->3)-beta-GlcNAc-(1-->3)-beta-Gal-(1-->4)-Glc-beta-OBn	1
glycated serum proteins	1
glycosylated hemoglobin	1
α-2,6 sialylation	1
Galactose-alpha-1,3-galactose (alpha-Gal)	1
N-glycolylneuraminic acid (NeuGc)	1
β-galactopyranoside	1
α-linked sialic acid	1
innermost GlcNAc	1
N-terminal V3 loop glycan	1
N-glycan of CCP-2	1
N-glycans of CCP-4	1
GC mucins	1
α2-3-linked sialic acids	1
triantennary trigalactosylated glycans	1
tetraantennary tetrasialylated glycans	1
Lea/Leb glycans	1
shielding glycans	1
Tn/Sialyl-Tn-epitopes	1
2,6-linked sialylated N-glycans	1
agalactosylated structures	1
Sialyl Lewis(a)	1
α2,6sialylation	1
core-fucosylated residues	1
core-fucosylated structures	1
trianntenary structure	1
tri-antennary tri-sialylated mono-fucosylated glycan of alpha-1 antitrypsin	1
Lactosylceramide	1
sialyl-Tn (sialic acid alpha2,6GalNAc)	1
9-O-acetylation	1
6'-sulfo sialyl Lewis(x)	1
Forssman disaccharide (GalNAcα1-3GalNAcβ)	1
terminal alpha-GlcNAc	1
terminal beta-GlcNAc	1
T(N)	1
ST(N)	1
2,6-ST	1
N-deacetylsialyl Lewis X ganglioside	1
Sialyl Lewis X (sLex)	1
CD90	1
congenital defects of glycosylation	1
glycosylated plasma fetuin-A	1
glycan ratio m/z 2378/1914	1
sialylated oligosaccharides	1
N-acetylglucosaminylasparagine	1
C-mannosylation	1
glycosylated PAI-2	1
sialylated O-linked glycans (MUC1-ST)	1
high-mannose core structures of N-linked glycans	1
α1,6-fucose	1
NeuAcα2,3Galβ1,3GalNAc	1
glycophore	1
CA125 antigen	1
Lipid-linked oligosaccharide (LLO)	1
Glycated Serum Albumin	1
glycosylated pyridinoline (gPYD)	1
total deoxypyridinoline (tDPD)	1
free pyridinium crosslinks (fPYD)	1
free deoxypyridinoline (fDPD)	1
sulfa-Tn antigens	1
O-N-acetylglucosamine glycosylation	1
mucin core 2 tetrasaccharide	1
Globo	1
serum invasive trophoblast antigen (ITA)	1
HbA(1C)	1
α1,6-linked fucosylation	1
glycosylated prostate-specific antigen	1
beta1	1
beta6	1
beta7	1
mucin-type O-glycosylation	1
SG35	1
SG45	1
SG46	1
N-linked glycan chains	1
complex N-linked glycans with sialic acid chains	1
glycosylation-dependent epitope of the CD31 antigen	1
glycosylated alpha-fetoprotein	1
HNK-1 sulfated carbohydrate epitope	1
N- and O-glycosylation	1
sialylated O-linked sugar chains	1
MUC1 glycoform	1
truncated glycosylation	1
α1,3-mannosylation	1
CD34	1
monosialylated alpha-fetoprotein	1
asparagine-linked carbohydrate structures	1
O-linked oligosaccharides with the core-2 structure	1
high-mannose or hybrid structures	1
Siaα2,6Galβ1,4GlcNAc (Sia6LacNAc)	1
core 2-type O-glycans	1
fucose-α(1-2)-galactose	1
α-galactose adjuvant motif	1
anthocyanins	1
sialoglycoprotein gp114	1
basolateral p58	1
highly sialylated O- and N-linked complex carbohydrates	1
sulfated glycan (Galβ1-3[SO3-GlcNAcβ1-6]GalNAc)	1
fucosylated glycan (GlcNAcβ1-3(Fucα1-2Galβ1-3)GalNAc)	1
core 4 glycan (GlcNAcβ1-3[GlcNAcβ1-6]GalNAc)	1
sialylated/agalactosylated ratio	1
Nε-fructosyl-lysine	1
Nε-carboxymethyl-lysine	1
Nε-carboxyethyl-lysine	1
oligomannose and hybrid type glycans	1
sulfated and α2-3- linked sialic acid glycoconjugates	1
high-mannose and complex-type N-glycans	1
N-glycans of MUC2	1
N-glycan sialylation	1
tri-galactosylated (G3)	1
antenary fucosylated (FUC_A)	1
low branching (LB)	1
non-sialylated (S0)	1
monogalactosylation (G1)	1
core fucosylation (FUC_C)	1
biantennary galactosylation (A2G)	1
biantennary (BA)	1
agalactosyl bi-antennary glycans	1
monogalactosyl bi-antennary glycans	1
#3410	1
#3510	1
#4510	1
hyperglycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP)	1
hybrid type glycans	1
m/z 1708	1
m/z 1914	1
m/z 1708/1914 ratio	1
high mannose type N-glycans	1
sialylated O-linked glycan	1
N-glycan of high mannose and/or hybrid type	1
bisecting-GlcNAc	1
type 1-(Galβ-3GlcNAc)-terminating backbone sequence	1
type 2-(Galβ-4GlcNAc) analog	1
mono-sulfated type 2 chain with 6-sulfation at the penultimate N-acetylglucosamine	1
Wisteria floribunda agglutinin positive Mac-2 binding protein (WFA+-M2BP)	1
G0 glycoform	1
G1 glycoform	1
G2 glycoform	1
α-2,3-terminal sialic acid	1
3-deoxyglucosone	1
advanced glycation endproducts (AGEs)-Nε-carboxymethyl-lysine (CML)	1
Nω-carboxymethylarginine (CMA)	1
3-deoxyglucosone-derived hydroimidazolone (3DG-H)	1
o,o'-dityrosine (DT)	1
methylglyoxal-derived hydroimidazolone (MG-H1)	1
glucose monomycolate (GMM)	1
Early- and advanced-glycation products (EGAs and AGEs)	1
3-O-alpha-L-fucopyranosyl-2-acetamido-2-deoxy-D-glucopyranose	1
2-acetamido-2-deoxy-3-O-(alpha-L-fucopyranosyl)-4-O-(beta-D-galactopyranosyl)-D-glucopyranose	1
α-1 acid glycoprotein	1
serum amyloid A	1
α(1,6)linked fucose residues	1
alpha-2,6-sialylated Hp	1
alpha-1,6-fucosylated Hp	1
alpha-D-galactose-binding plant lectin frutalin	1
differentially glycosylated form of CD3gamma	1
hyper-sialylation	1
N-linked carbohydrate groups	1
core alpha-1,6-linked fucose	1
under-glycosylated forms of MUC1	1
fully glycosylated MUC1	1
glycosides	1
H	1
high mannose form	1
Wheat Germ Agglutinin-reactive glycoproteins	1
sialyl Lewis A antigen	1
GP17	1
G12n	1
Fuc	1
high mannose and complex N-glycans	1
trigalactosylated (G3)	1
trisialylated (S3)	1
glycan 9200	1
fucosylated PON1	1
Neu5Acalpha2,6Gal	1
Neu5Acalpha2,3	1
Glycated Albumin	1
14-3-3 protein	1
N-linked oligosaccharide decorated with sialic acid	1
Maillard reaction product X (MRX)	1
fucosylated-sialylated glycans	1
hybrid monosialylated triantennary glycopeptide	1
(β-1,4) triantennary N-linked glycan	1
α-1,6-fucosylated PSA	1
O-glycan Core 1	1
core 2 [Galbeta1 --> 3(GlcNAcbeta1 --> 6)GalNAc]	1
alpha2,3-linked sialic acid	1
glycosylated CEA N-A3	1
N-linked carbohydrate chain	1
DF3 antigen	1
poly N-acetyllactosamines	1
core 2 beta-1,6 branch	1
CC49 epitope	1
CSLEX-1 epitope	1
SM-3 peptide epitope	1
NA3F	1
NA3	1
N-linked oligosaccharide chains containing sialic acid residues	1
hyperglucosylation	1
EA 1	1
beta1,6-branched polylactosamine	1
Tn-MUC1 (GalNAc-α-MUC1)	1
N- and O-linked carbohydrates	1
α2-6 sialylated N-glycans	1
Man8/9 N-glycans	1
Man5 N-glycans	1
Glycated CD59	1
galactosylated A1AT	1
fucosylated A1AT	1
A1AT containing poly-LacNAc	1
glycated Tf	1
NeuAc	1
beta Gal	1
alpha Fuc	1
ELF	1
galactose-deficient IgA1 (Gd-IgA1)	1
glycosylation at Asn51 and Asn78 sites	1
alpha2,6-sialic acid	1
O-glycosylated forms of T cell surface molecules	1
Advanced Glycation End Products (AGEs)	1
α1-2Fuc glycan	1
(N-acetylhexosamine)2 (deoxyhexose)(mannose)3 (N-acetylglucosamine)2	1
(hexose)(N-acetylhexosamine)2 (deoxyhexose)(mannose)3 (N-acetylglucosamine)2	1
(N-acetylneuraminic acid)(α2-6)galactose/N-acetylgalactosamine	1
truncated glycans	1
glycan at position 3	1
glycan at position 11	1
glycan component of gp41	1
Tn antigen (GalNAc alpha-O-Ser/Thr)	1
heparan sulfate (HS) oligosaccharide	1
N-linked and O-linked glycosylation	1
disaccharides	1
trisaccharides	1
MPL	1
VVA	1
SLeX	1
SLea	1
diSLeX	1
GlcNAc beta1-6 branched N-glycans	1
hypoglycosylated N-glycans	1
alpha-D-Neup5Ac-(2-->3)-beta-D-Galp-(1-->4)-D-GlcpNAc	1
234 gp120 glycan	1
276 gp120 glycan	1
disialyl Lewis(a)	1
sialyl 6-sulfo Lewis(x)	1
sialyl Lewis(a)	1
core-2-based Thr-linked O-glycan	1
GalNAcβ1,4GlcNAcβ	1
Sialyl-Tn antigen (STn)	1
Lewis type 2 antigens	1
glycosylated rHuG-CSF	1
α2-3 Linked N-Acetylneuraminic Acid	1
Core 1 O-Glycans	1
2G12 neutralizing epitope	1
biantennary fucosylated glycan without galactose (H3N4F1)	1
biantennary fucosylated glycan with two galactose (H5N4F1)	1
non-fucosylated glycans	1
sialyl Lewis a (SLea)	1
glucuronic acid/sulphate containing N-linked glycans	1
disialylated triantennary glycans	1
trigalactosylated, triantennary, disialylated, and trisialylated glycans	1
biantennary digalactosylated glycans with core fucose	1
sialylation of the CD45RA region	1
differential sialylation of the CD45RB region	1
sialyl lewis X (SLex)	1
branched O-linked glycans	1
high-mannose type oligosaccharide structures	1
PSA glycosylation	1
glycan N238	1
mannosyl-β1-phosphomycoketide	1
glucosylated MOG	1
sialyl-Lewis X (SLex; NeuAc alpha 2,3Gal beta 1,4(Fuc alpha 1,3)-GlcNAc-)	1
Nε-(Carboxymethyl)lysine	1
Glycosylated MUC1	1
alphaGalNAc	1
O-glycosylated fragment	1
3-sulfo Lewis x	1
6-sulfo Lewis x	1
A antigen	1
glycated Cu,Zn-superoxide dismutase	1
Glycated Hemoglobin	1
cancer associated glycosylation	1
4F2 heavy chain antigen	1
glycated lipoproteins, LDL	1
polylactoaminoglycans	1
polyglycosylceramides	1
lactotriaosylceramide	1
neolactotetraosylceramide	1
globotetraosylceramide	1
poly-sialic acid	1
hexosylceramide	1
carbohydrate	1
N(epsilon)-fructoselysine	1
N(epsilon)-(carboxymethyl)lysine	1
malondialdehyde-lysine	1
histo-blood group antigens	1
d-ribose	1
Tn antigen (α-O-GalNAc-Ser)	1
Tn antigen (α-O-GalNAc-Thr)	1
N-glycosylated CD97	1
core-2 O-glycoform	1
Sialyl-Lewis x	1
glycosylated factor	1
immaturely glycosylated form	1
N-glycosyl chains	1
glycosylated full-length gp120	1
carbohydrate units	1
glycan N301	1
under-O-glycosylated IgA1	1
Lamp-1	1
sialyl Le(x) (sLe(x))	1
3-O-sulfated oligosaccharide chains terminated by a sulfated N-acetyllactosamine	1
sulfated Lewis A determinant	1
6-O-sulfated chain terminated by a sulfated H-2 determinant	1
glycated IgG	1
Con A-reactive moieties	1
LCA-reactive moieties	1
asialyl T	1
Asn58 glycosylation	1
Tn antigen (GalNAc alpha 1-O-Ser/Thr)	1
glycosylated LCs	1
Neu5Ac (alpha2,6) Gal/GalNAc	1
H-type-1 antigen	1
glycosylated rh-G-CSF	1
biantennary fucosylated glycan modification	1
sulfated lactosaminoglycan chains	1
sialokeratan sulfate epitope	1
branched mannose and N-acetylglucosamine	1
EV glycan signature	1
O-linked glycan structures	1
serum alkaline phosphatases	1
beta1-6 branched N-linked oligosaccharides	1
CD66c	1
core 1 O-glycan motif	1
Wisteria floribunda agglutinin (WFA)	1
SialylTn (STn)	1
6SO4-Gal	1
N-glycoform	1
MUC1-TF	1
glycans present on gp120	1
alpha2,3-sialyl residues	1
glycated peptides	1
Tn-antigen (GalNAc-O-Ser/Thr)	1
IgG Fc N-glycosylation	1
alpha2,6-linked N-acetyl-D-neuraminic acid	1
alpha2,3-linked N-acetyl-D-neuraminic acid	1
unique N-glycan (Tf-1)	1
N-glycan similar to that of serum transferrin (Tf-2)	1
glycosylation aberrancies	1
α2,3sialylated T-antigen	1
mucin glycopeptides	1
6'-sulfo-sLe X	1
GlcNAc5,Hex6,Neu5Ac3	1
GlcNAc6,Hex7,Neu5Ac4	1
GlcNAc4,Hex5,Fuc,Neu5Ac	1
GlcNAc5,Hex6,Fuc,Neu5Ac2	1
GlcNAc6,Hex7,Fuc,Neu5Ac3	1
Fucalpha1-2Gal	1
bisecting GlcNAc-beta(1-->4) linkage	1
oligosaccharide markers	1
calprotectin	1
advanced oxidation protein products (AOPP)	1
glycosylation pattern of Ncr1-Noé	1
N-glycosylated NPC2	1
poly N-acetyl lactosamine	1
core-type fucosylation	1
N ε -carboxymethyl-lysine	1
N ε -(γ-glutamyl)lysine	1
glycated human serum albumin	1
glycated apolipoprotein A-I	1
MUC2 mucin	1
galactose-deficient hinge-region O-glycans (Gd-IgA1)	1
Gal3C-S	1
Lewis x epitope	1
sialylated Lewis x epitope	1
glycosylation profile	1
high mannose-glycosylated	1
PSA glycoforms	1
O-mannosylation	1
sialoglycoprotein CD43	1
Lactose	1
hypoglycosylated form of CD86	1
Lewis x carbohydrate epitope (Le(x))	1
mannose 6-phosphate	1
beta-D-Gal p-(1-->3)-alpha-D-Gal pNAc-(1-->O)-L-threonine	1
N-linked oligosaccharide moieties	1
sialyl-transferase	1
fucosyl-transferase	1
cell surface carbohydrates	1
2'-O-alpha-L-fucosyl-N-acetyllactosamine	1
3'-O-alpha-L-fucosyllactose	1
O-glycosidic-linked carbohydrates	1
light chain carbohydrate	1
Sialyl-Lex (sLex)	1
Pregnancy-Specific beta 1-Glycoproteins	1
blood group oligosaccharides	1
high-mannose N-linked carbohydrate chains	1
complex N-linked carbohydrate chains	1
high mannose glycoproteins	1
α-fetoprotein	1
chondroitin sulfate A	1
sialyl-Lewis(x)-saccharopeptides	1
high-mannose oligosaccharide	1
hybrid oligosaccharides	1
alpha-galactose residues	1
N-linked glycosyl units	1
glycosylation-rich region	1
WFA-sialylated MUC1	1
hypoglycosylated form of mucin	1
Carcinoembryonic Antigen	1
N-linked glycosylation epitope	1
carbohydrate antigen	1
Thomsen-Friedenreich (T)-antigen	1
high-mannose-type oligosaccharides	1
high-mannose type oligosaccharides	1
hybrid-type glycoproteins	1
(Hex)4(HexNAc)3	1
(Hex)4(HexNAc)4	1
(Hex)5(HexNAc)4	1
IgG agalactosylation	1
H3N4F1-a	1
H3N4F1-b	1
H4N3S1F1-e	1
H4N4F3SA	1
H4N6F2	1
H4N6SA	1
H5N4FSA	1
Sialyl Lewis(X)	1
GP21	1
GP22	1
agalactosylated glycoform of ASCA IgG	1
sialylated core 1 O-glycans	1
multifucosylated tetraantennary N-glycans	1
sialic acid receptors	1
fucosylated AFP	1
ICAM-1	1
MUC18	1
Tn neoantigen (GalNAcα1-O-Ser/Thr)	1
glycan age index	1
glycan age	1
agalactosylated	1
monogalactosylated	1
digalactosylated	1
complex-type biantennary N-glycans	1
Gal(β1-3)GalNAc (T-antigen)	1
Sia(α2-3)Gal(β1-3)GalNAc (Sialyl T)	1
Sia(α2-3)Gal(β1-3)Sia(α2-6)GalNAc (disialyl-T)	1
triantennary complex-type glycans	1
alpha-Gal antigen	1
LacNAc-containing glycans	1
paucimannosidic structures	1
glycan 2	1
agalactosylated (G0) Abs	1
glycosylated 400-kD precursor species	1
glycosylated isoforms	1
Glc1Man9GlcNAc2	1
Man8GlcNAc2	1
Man7GlcNAc2	1
N-linked oligosaccharide	1
alpha-galactose-containing oligosaccharides	1
highly branched sugar chains	1
Gal beta 1----4(Fuc alpha 1----3)GlcNAc beta 1----	1
Neu5Ac alpha 2----3Gal beta 1----4GlcNAc beta 1----	1
fucosylated trimannosyl core	1
bisected biantennary sugar chain	1
glycosylated CD4	1
galactosides	1
glycosylated fraction	1
N-acetyl-lactosamine	1
Thomsen-Friedenreich (T) antigen	1
D-dimer	1
O-glycosidically linked proteins (NeuAcalpha2,6 Galbeta1,3GalNAcalpha1,0 Ser/Thr or sialyl-T-antigen)	1
underglycosylated mucin 1 (uMUC1)	1
9-O-acetylated sialoglycans	1
hyperglycosylated MUC1	1
N-glycan composition	1
3'-sialylated, 6'-sulfated LNnT	1
3'-sialylated, 6-sulfated core 1	1
disulfated core 1	1
mono- and disialylated sugar chains	1
HNK-1-capped core M2 glycan	1
high-mannose N-linked chains	1
oligomannose glycans	1
(GlcNAc)(2)(Man)(5)	1
(GlcNAc)(2)(Man)(4)	1
(GlcNAc)(2)(Fuc)(0-2)(Man)(2-3)	1
sialyl-Lewis C	1
HPA-positive glycotopes	1
E-selectin ligands	1
P-Selectin	1
glycosylated SIV gp120 core	1
Sd(a) antigen	1
N-linked sugars of high mannose types	1
sialyl Le(X)	1
oligosaccharide chain	1
K06 epitope of human CD43	1
cCLLa	1
Glycopeptides	1
sialyl-Lewisc	1
α1-3,4 fucosylation	1
C2-O-sLeX	1
tri antennary trigalactosylated trisialylated glycans	1
monoantennary glycan structures	1
bi and triantennary, di- and trigalactosylated, di- and trisialylated	1
9-O-acetyl-N-acetylneuraminic acid (Neu5,9Ac2)	1
9-acetamido-9-deoxy-N-acetylneuraminic acid (Neu5Ac9NAc)	1
β-galactofuranosyl (β-Galf) residues	1
carbohydrate antigen 19-9 (CA19-9)	1
carbohydrate antigen-S27 (CA-S27)	1
WFA-positive MUC1 (WFA<sup>+</sup>-MUC1)	1
WFA-positive M2BP (WFA<sup>+</sup>-M2BP)	1
sialyl Lewis(X) (sLe(x))	1
G2FN/G1FN	1
glycosylated Hb	1
sialyl-Le(a)	1
Thomsen-Friedenreich epitope	1
NƐ-(carboxylmethyl) lysine	1
glycosylated NTCP	1
Asn-linked oligosaccharide moieties	1
HCN5-CHOs	1
HCN1-CHOs	1
N-linked glycosylation sequences	1
sialosyl dimeric Le(x)	1
C gamma 2 structures	1
glycosilated surface nucleolin	1
galactose-deficient (Gd)-IgA1	1
high-mannose or hybrid types of oligosaccharides	1
asialofetuin-A	1
fully glycosylated	1
glycosylated DNA	1
polyglycylation	1
nonglycosylated amylin	1
N-glycosylated form	1
glycosylation inhibiting factor (GIF)	1
C-III<sub>0b</sub>	1
C-III<sub>2</sub>	1
galactose β1-4 N-acetylglucosamine (Gal-GlcNAc)	1
Lec	1
mucin core 2	1
glycated CD59	1
two glycan forms of fPSA	1
fully glycosylated forms of MUC1	1
differentiation-dependent glycoforms	1
DU-PAN-2	1
GPI-anchored glycoprotein	1
tri-antennary complex type glycan (m/z 3195)	1
glycan ratio (m/z 3195/1914)	1
di-sialylated glycans	1
mono-sialylated ApoC-III	1
desialylated A2HSG	1
capsular polysaccharides	1
sialyl Lewis X (sLeX) antigen	1
IgA1	1
core-fucosylated tetraantennary oligosaccharides	1
N-linked fetuin glycans	1
core 1 sialyl Lewis A	1
Thomsen-Friedenreich-antigen	1
core fucosylated α2-6 monosialo-biantennary structure	1
truncated O-linked glycans	1
carbohydrate-induced conformational tumour-epitope	1
Glycosphingolipids	1
Hex5HexNAc4NeuAc1dHex1	1
monosialylated	1
unfucosylated	1
mannosylation-6 phosphate	1
Lewis blood group family antigens	1
Lex	1
sialyl Lexa	1
heparan sulfate (HS)	1
glycosylated Eng	1
glycosylated Flt-1	1
glycopeptide	1
sialyl moiety	1
trisaccharide glycan	1
core 2 O-glycan structures	1
high-mannosylation	1
total sialylation	1
intact glycans	1
altered glycans	1
multibranched complex-type N-glycans	1
tri-antennary complex-type N-glycans	1
bi-antennary complex-type N-glycans	1
Neu5Acα2-3(6-O-sulfo)Galβ1-4GlcNAc	1
N-Linked glycans	1
tyrosine sulfate	1
hybrid, oligomannose, and biantennary digalactosylated monosialylated glycans (M5A1G1S1, M8, and A2G2S1)	1
bisecting glycans (A2B, A2(6)BG1)	1
monoantennary glycans (A1)	1
triantennary trigalactosylated trisialylated glycans (A3G3S3 and FA3G3S3)	1
SiaTn	1
6-OSulfo-TF	1
6-OSulfo-LN	1
SiaLea	1
fucosylated biantennary oligosaccharides	1
sialyl(NeuGl)-TF, Gal beta 1-3(NeuGl alpha 2-6)GalNAc	1
sialylated trisaccharides NeuAc alpha 2-3Gal Beta 1-3GalNAc	1
L-fucose	1
sialic acid-containing glycans (sialosides)	1
multi-multiantennary branched N-glycans	1
mucin-type Core 1 and Core 2 sialylated O-glycans	1
glycopatterns	1
α2,6-sialylated N-glycan	1
N-linked complex sugar chain	1
I antigen	1
blood group H determinant	1
N-glycosylation motifs	1
α2,6- and α2,3-sialylated isomers	1
O-linked sialylated T-antigen [Neu5Ac(alpha2-3)-Gal(beta1-3)-GalNAcalpha1]	1
carboxymethyllysine	1
fructose	1
core 2 o-glycans	1
mistletoe lectin I	1
glycosylated endosialin	1
sialyl Lewis C	1
Lewis X (CD15/SSEA-1)	1
triantennary N-linked glycans	1
bisected hybrid-type glycans	1
blood group A trisaccharide (BG-Atri)	1
sialyl 6-sulfo Lewis X (G152 glycan)	1
cyclic sialyl 6-sulfo Lewis X (G159 glycan)	1
tetraantennary glycan	1
glycoxidation products	1
AβPP 115 kDa	1
N-glycosylated residues	1
hybrid/complex type glycopeptides with mannose as hexose units	1
agalactosylated fucosylated structures	1
asialylated fucosylated structures	1
glycation adducts	1
Tn glycoform	1
3-nitrotyrosine	1
N(epsilon)-carboxymethyl-lysine	1
3-deoxyglucosone-derived hydroimidazolone	1
N-formylkynurenine	1
Glyc-AChE	1
Glyc-BuChE	1
glycosylated gp120	1
lactamized neuraminic acid	1
sulfated sialylparagloboside	1
ganglioside GM4	1
tri- or tetraantennary complex type glycans	1
sialylated tri- or tetraantennary complex type glycans	1
N-glycosylated Asn(88)	1
Sialyl Lewis a (Si-Le(a))	1
type 2 Lewis antigens	1
type 1 Lewis antigens	1
N(epsilon)-[carboxymethyl]-lysine (CML)	1
sialyl Lewis-type oligosaccharides	1
advanced glycosylation end product (AGE)	1
overfucosylation	1
undersialylation	1
D-glu-LPPA-1	1
D-gal-LPPA-1	1
α-D-glucosylated eugenol	1
sugar chain composition	1
glycosylated ALCAM	1
O-glycosylated tandem repeat domain	1
N-acetylgalactosaminyltransferase 3 (GalNAc-T3)	1
N-glycanase-treated basigin	1
basigin	1
saccharides	1
sLex moiety	1
N glycosylation	1
glucosylation	1
Lactosylceramide (LacCer)	1
high-mannose-type, nonsialylated, nonfucosylated carbohydrate moieties	1
hypogalactosylated hinge region	1
Hyaluronan	1
Peanut Agglutinin	1
Man6	1
Man7	1
6'-sulfo-sialyl Lewis X	1
2-naphthylmethyl 3,4,6-tetra-O-acetyl-beta-D-galactopyranosyl-(1 --> 4)-2-acetamido-3,6-di-O-acetyl-2-deoxy-beta-D-glucopyranoside	1
2-naphthylmethyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-beta-D-glucopyranosyl-(1 --> 3)-2,4,6-tri-O-acetyl-beta-D-galactopyranoside	1
2-naphthylmethyl 2,3,4,6-tetra-O-acetyl-beta-D-galactopyranosyl-(1 --> 3)-2-acetamido-4,6-di-O-acetyl-2-deoxy-alpha-D-galactopyranoside	1
2-naphthylmethyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-beta-D-glucopyranosyl-(1 --> 3)-2-acetamido-4,6-di-O-acetyl-2-deoxy-alpha-D-galactopyranoside	1
2-naphthylmethyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-beta-D-glucopyranosyl-(1 --> 6)-2-acetamido-3,4-di-O-acetyl-2-deoxy-alpha-D-galactopyranoside	1
Fucosylation	1
sialylated core-2 O-glycans	1
O-GalNAc	1
nonreducing terminal GlcNAc residues	1
sialyl Lewis x structure	1
mammalian-like N-glycans	1
core-fucosylated N-glycan	1
beta1,6GlcNAc-branching	1
maltooligosaccharide	1
glycans released from bovine ribonuclease B	1
glycans released from bovine fetuin	1
glycans released from chicken ovalbumin	1
Neu5Acα2-6GalNAcα-glycan	1
α2, 3 sialic acid in SLea	1
N156	1
N262	1
N410	1
CMP-sialic acid	1
high mannose- and two complex-type glycans	1
N-glycans of the oligomannosidic type	1
fucose residues	1
triantennary and biantennary structures	1
G2F glycosylation profile	1
N-linked glycan composition	1
beta-1,6-GlcNAc branching	1
alternatively glycosylated MUC1	1
alternatively glycosylated MUC5AC	1
Axl N-glycans	1
MUC1 O-glycosylation	1
non-human and human glycans	1
Neu5Acα2,6-Tn	1
Neu5Gcα2,6-Tn	1
Glycosaminoglycans	1
Glc3Man9GlcNAc2	1
Glc3Man7-9GlcNAc2	1
sialylated O-glycosylated ligand CD99	1
sialic acid-containing glycan	1
glycosylated variants	1
complex glycosylated mature form	1
GSL-4A	1
O-linked glycan chains	1
N-linked glycan attached to asparagine 61	1
complex N-glycan of the V3 loop	1
Lewis y	1
G81	1
Lewis histo-blood group and related glycans	1
extended Lea and Lex containing glycans	1
sialyl-Tn (STn) antigen	1
O-glycan compositions (33-mer hinge core peptides + xGalNAc + yGal + zNeu5Ac)	1
monogalactosylated triantennary structure	1
polysaccharide-based multi-ingredient supplement	1
simple glycans	1
monoglucosylated glycans	1
high-mannose N-glycan	1
Gal	1
hybrid glycans	1
beta1,6GlcNAc-branched N-glycans	1
sialylated keratan sulfate	1
trisialylated triantennary structures	1
tetrasialylated triantennary structures	1
Thomsen-Friedenreich antigen (TFα; Galβ1-3GalNAcα)	1
GalNAc Le(x)	1
Sialic Acid (Sia)	1
mucin 1 glycans	1
sialyl-Le X	1
VIM-2	1
glycosylated hemoglobin (HbA(1c))	1
6'-sulfo-sialyl Lewis X (6'-sulfo-sLe x)	1
carboxymethyllysine (CML)	1
oxidized phosphatidylcholine (Ox-PC)	1
MUC1-N	1
CD24	1
T-antigen (Gal beta(1-3)GalNAc alpha 1-O-R)	1
fucosylated exosome	1
terminal α2,6-sialylation	1
glycosylated isoforms of alpha-1-antitrypsin	1
tetrasaccharide-core O-linked carbohydrate moieties	1
Tn (GalNAc-Ser/Thr)	1
STn (NeuAcα2,6GalNAc-Ser/Thr)	1
fucose-terminated glycans	1
6-sulfo-sialyl Lewis(x) oligosaccharide	1
GlcNAc residues	1
N-glycosylation site deletions	1
bi- and triantennary glycans	1
Thomsen-Friedenreich disaccharide	1
high Mannose oligosaccharides	1
biantennary galactosylated N-glycans	1
LNT	1
LSTa	1
LSTc	1
sialyl-Tn antigen (NeuAc-GalNAc-O-Ser/Thr)	1
desialylation	1
alpha3-fucosylation	1
O-glycosidic linkages to sugar residues	1
sialyl Lewis-X (sLeX)	1
sLex glycopolymers	1
fucosylated triantennary glycans	1
DG9-glycan index	1
alpha2,3-linked sialic acid residues	1
poly-N-acetyllactosaminyl side chains	1
sialyl Lex structures	1
Asn-linked core oligosaccharide	1
Ser/Thr-linked mannose	1
O-linked carbohydrate unit	1
PD-L1 N-link glycosylation	1
differential glycosylation	1
fucosylated GP73	1
glycosylated mature molecules	1
glycated hCD59	1
D-N-acetylglucosamine	1
glucosylceramide	1
GnGn structures	1
Congenital disorder of glycosylation	1
ALG9-CDG	1
ALG3-CDG	1
COG6-CDG	1
MGAT2-CDG	1
SLC35A2-CDG	1
O-Acetyl-GD3	1
sialyl Lewis X tetrasaccharide	1
A type histoblood group epitope	1
sialylated glycoforms	1
tandem core repeat sequence	1
core-fucosylated alpha-fetoprotein	1
Bacteroidales O-glycosylation motif	1
heparan sulfate-like glucosaminoglycan	1
Gal(beta 1-3)GalNAc	1
bacterial polysaccharides	1
SLEX	1
SLEA	1
tri-antennary carbohydrate moieties	1
bi-antennary moieties	1
mono-antennary	1
tri- and tetra-antennary oligosaccharides	1
hyperglycosylated N-terminal CD109 fragment	1
glycosylation of CD83	1
core oligosaccharide structure	1
glycan epitope	1
sialyl Tn (STN), NeuAcα2-6-GalNAc	1
α(1,2)fucosylated glycans	1
bisected hybrid or complex type glycan	1
biantennary fucosylated complex type glycan	1
triantennary bisected complex type glycan	1
Thomsen-Friedenreich (TF) human tumor antigen	1
antennary fucosylated N-glycans	1
GlcNAcylated AACT	1
2534 m/z N-glycan	1
sialyl Lewis a (sLe(a))	1
sulfated and/or sialylated glycans	1
N-glycosylation pattern	1
297-11A-sulfated glycans	1
serum glycan profiles	1
Dol18/Dol19	1
galactose-6-sulfated oligosaccharides	1
disialyl core 1 O-glycans	1
Sialyl LewisA (CA19-9)	1
Tn/Sialyl-Tn on MUC1	1
tri-antennary and tetra-antennary glycans	1
asialo triantennary N glycan	1
sialyl Lewis X antigen (sLeX)	1
alpha2,3-sialylated human alpha(1)-acid glycoprotein (AGP)	1
glycosylated surface proteins	1
aberrantly glycosylated form	1
GlcNAc-branched N-glycans	1
N-acetylglucosaminylated glycans	1
α2, 6-sialylated glycans	1
glycosamine glycans	1
glycosylated hemoglobin (HbA1c)	1
sLe(a)	1
N-Linked oligosaccharides	1
underglycosylated IgA1	1
defective glycosylation	1
glyco-chains	1
beta-N-acetylglucosamine	1
glycated serum protein (GSP)	1
glycosylation at position 415	1
gp130	1
galactose-N-acetylgalactosamine	1
β-(1→3)-glucan	1
epitope	1
3-O-glucosylation	1
1,5-anhydroglucitol	1
carbohydrates	1
branch alpha(1,3)-fucosylated triantennary glycan	1
bisecting core alpha(1,6)-fucosylated biantennary glycan	1
Gal/GalNAc	1
mannosylated N-glycans	1
Manα1-3Man	1
Manα1-6Man	1
CD24-associated carbohydrate epitopes	1
galactosylated streptavidin	1
2-keto-Gal	1
transferrin glycoforms	1
KL-6/MUC1	1
glycosylated CD133 protein	1
MUC1-Tn	1
Thomsen-Friedenreich antigen (T antigen) disaccharide, beta-D-galactose-(1-->3)-alpha-N-acetyl-D-galactosamine (beta-D-Gal-(1-->3)-alpha-D-GalNAc)	1
Gal beta 1----4GlcNAc	1
Gal beta 1----3GlcNAc	1
2,3-sialylated glycans	1
LewisX (LeX)	1
N-linked glycan at position 386	1
sialyl Lewis x (sLe<sup>x</sup>)	1
A2	1
disialylated O-glycans	1
monosialylated O-glycan	1
6'-sulfo-sialyl Lewis x	1
high-mannose-type N-glycans	1
single-GlcNAc-type N-glycans	1
sialyl LewisX (sLeX)	1
lacto-N-neotetraose	1
high-mannose-type saccharides	1
blood-type antigens H, A, B, Le(a), Le(b), Le(x), Le(y), sialyl-Le(a)	1
terminal mannose, terminal N-acetylglucosamine, 6-sulfogalactose residues	1
N-glycan with Galβ1-4Galβ1- motif	1
α2,6-sialylated glycans	1
outer arm fucosylation	1
sialyl-Le(x)-containing glycan NeuAc(alpha2-3)Gal(beta1-4)[Fuc(alpha1-3)]GlcNAc-R	1
CD75s gangliosides	1
high molecular weight hyaluronan (HMW-HA)	1
anti-laminaribioside carbohydrate IgG antibodies (ALCA)	1
anti-chitobioside carbohydrate IgA antibodies (ACCA)	1
anti-mannobioside carbohydrate IgG antibodies (AMCA)	1
complex biantennary glycan	1
N332 oligomannose glycan	1
N-glycolyl-neuraminic acid (Neu5Gc)	1
biantennary N-glycans	1
glucuronoxylomannan	1
fucosylated biantennary disialylated oligosaccharide	1
glycoprotein 130 (gp130)	1
Galbeta1,3GalNAc alpha2,3-sialyltransferase	1
large free hCG alpha	1
Gc protein	1
sialic acid links alpha(2,3)Gal/GalNAc and alpha(2,6)Gal/GalNAc	1
galactosylceramide (Gal beta 1-1'Cer;GalCer)	1
sialylated Tn antigen	1
sialylated glycopeptides	1
High-mannose glycosylation	1
Glycodelin A	1
C-CAM	1
Leb carbohydrate antigen	1
glycoGag	1
glycoMA	1
epitopes	1
hexosyl-1-phosphoisoprenoids	1
mannosyl-beta1-phosphodolichols	1
mannose-rich sugar chain	1
complex carbohydrate structure	1
N-acethylhexosamine	1
bisected oligosaccharides	1
non-fucosylated and hybrid oligosaccharides	1
bisected non-fucosylated hybrid glycans	1
complex type oligosaccharides	1
Galβ1-3GlcNAcβ1-3Galβ1-4GlcNAc	1
Galβ1-3GlcNAcβ1-3Galβ1-4GlcNAcβ1-6(Galβ1-3)GalNAc	1
Glycan epitope-Tn/STn	1
GD1b	1
fibrinogen-derived glycan peak	1
sialosyl-Le(a)	1
Sda	1
high mannose-type N-glycans	1
α2,6-NeuAc glycans	1
α2,3-NeuAc moiety	1
O-linked and N-linked sugars	1
N-linked carbohydrate residues	1
N-glycosylated MUC1-C	1
hyperglycosylated human chorionic gonadotropin (hCG-h)	1
advanced glycation endproduct (AGE)	1
ABH carbohydrate structures	1
sialylated N-acetyllactosamine	1
H and A antigens	1
binary N-acetyllactosamine	1
hyperglycosylated human chorionic gonadotrophin (hCG-h)	1
tri-antennary N-glycans containing a Lewis X-type fucose	1
di-fucosylated tetra-antennary N-glycans	1
bisected, afucosylated carbohydrates	1
Thomsen-Friedenreich antigen (Gal beta1-3GalNac alpha-)	1
apoC3 glycosylation index	1
alpha2-6-linked sialic acids	1
sialylated CD43 epitope	1
CD48	1
sialyl 6'-sulfo N-acetyllactosamine	1
glycan proteins	1
monofucosylated triantennary glycan A3G3F1S3	1
sialylated forms of Tn-antigen	1
sialylated forms of TF-antigen	1
T and Tn	1
sulfo sLex	1
sulfated sialyl Lewis-x (sLex)	1
sialylLex	1
sialylated epitopes	1
fucosylated tri-antennary glycan	1
high mannose oligosaccharides	1
core-2 sialyl Lewis X	1
H type 3	1
alpha2-6-linked sialic acid	1
short O-linked glycans	1
core-fucosylated, sialylated, and branched glycans	1
Thomsen-Friedenreich (TF) antigen (CD176)	1
N-linked glycoproteins	1
O-linked Gal beta 1,3GalNAc glycans	1
6'-sulfo-sLex	1
bisected fucosylated N-glycan structures	1
N-glycan fucosylation	1
fuco-oligosaccharides	1
Tn antigen (CD175)	1
fucosylated glycoproteins	1
sialyl-Lewis x (sLe<sup>x</sup>)	1
glycan at position 386	1
fucosylated triantennary N-glycan	1
Tn determinant (GalNAc alpha-O-Ser/Thr)	1
CD45RB	1
N-glycosylated protein	1
N-acetylneuraminate	1
α2-6-linked sialyl glycans	1
immunogamma globulin glycans	1
SSEA4	1
terminal Gal/GalNAc	1
Lewis a (Le(a)) antigens	1
Core 1	1
Core 3	1
Tf glycan isoform	1
terminal α2,6-linked sialic acid	1
fully-sialylated alpha-chain of complement 4-binding protein	1
short-chain O-glycans	1
b1,6 branched N-oligosaccharides	1
mono-glucosylates	1
Tn-glycopeptides	1
3-fucosyl-N-acetyllactosamine (CD15)	1
sulfoglucuronylcarbohydrate (SGC)	1
GalalphaGal	1
N-Glycosylated recombinant ricin B chain	1
Non-glycosylated ricin B chain	1
B152/B109 ratio	1
Agalactosyl biantennary glycans (FA2)	1
glycans containing the sialyl Lewis x epitope (A3F1G1 and A2F1G1)	1
S-linked STn	1
laminin α1	1
glycosylation motifs	1
cancer-associated carbohydrate antigens	1
glycosylated LT	1
CD30	1
tetrasaccharide composed of GalNAc, Gal, and two N-glycolylneuraminic acid residues	1
PI(4,5)P2	1
carboxyl amino acids	1
IgA1 O-glycosylation	1
H type-3 trisaccharide	1
sialyl-Tn antigen (STn)	1
Tn antigen (α-GalNAc-O-Ser/Thr)	1
alpha(2,3)-sialylation	1
beta1,6-branched oligosaccharides	1
isoglobotrihexosylceramide	1
core of the HIV type 1 envelope glycoprotein 120	1
cysteinylated albumin	1
fucosylated N-glycopeptides	1
glycosylated forms of proBNP 1-108	1
pGCD59	1
galactose-deficient IgA1	1
lenograstim	1
filgrastim	1
M1 epitopes	1
fucosylated neutral GSLs	1
G(M3) Ganglioside	1
heavily glycosylated protein	1
azido sialic acids	1
α2,6-sialic acids	1
G2FS(6)1	1
G2FS(3,6)2	1
G2FS(6,6)2	1
sialyl Tn	1
fucosylated sugar antigens	1
Glycosaminoglycan	1
alpha1,2-fucosylation	1
beta-N-acetylgalactosaminylation	1
core 3 (GlcNAcbeta1-3GalNAc)	1
Sd(a)/Cad-antigen-like structures	1
sulphated Lewis x	1
bifucosylation	1
Terminal Sialylation	1
Bisecting N-Glycans	1
alpha(2,8)-disialylated ganglioside GT1b	1
tetrasaccharide: Neu5Ac-α2,6-Gal-β1,4-GlcNAc-β1,4-GlcNAc	1
ALG1-CDG	1
GlcNAc and Man-bearing neoglycoproteins	1
asialoglycoprotein	1
NeuAcα(2-3)Galβ(1-3)GalNAc	1
Tn (GalNAcαThr/Ser)	1
T (Galβ1-3GalNAcαThr/Ser)	1
STn antigens	1
ABH group carbohydrate epitopes	1
alpha2,6-linked sialic acids	1
N-glycan markers	1
P5(NA2), P8(NA3), P10(NA4)	1
P1[NGA2F], P2[NGA2FB], P3[NG1A2F], P4[NG1A2F], P7[NA2FB], P8[NA3], P9[NA3Fb]	1
HER2 N-glycans	1
Tn antigen (GalNAcalpha1-Ser/Thr)	1
sialylated sulfated glycans	1
core 3-derived glycans	1
N-acetyl-D-hexosamines	1
NeuAc alpha 2-->3Gal beta 1-->3(4)GlcNAc	1
NeuAc alpha 2-->3Gal beta 1-->3GalNAc	1
NeuAc alpha 2-->6Gal beta 1-->4GlcNAc	1
Lewis x residues	1
N-acetylneuraminic acid (NeuAc)	1
Galactose 6-O-sulfate	1
MUC5AC-WGA	1
N-linked sugar chains	1
R5a	1
R5b	1
P5	1
log(R5a/P1)	1
log(R5b/P1)	1
Core 1 O-glycans	1
monosialylated Core 1 O-glycans	1
disialylated Core 1 O-glycan	1
polylactosamine-type N-glycans	1
T-nouvelle (Tn, CD175)	1
sialylated Tn (CD175s)	1
Thomsen-Friedenreich antigen (TF, CD176)	1
fucose- and sialic acid-containing N-glycans	1
CCPs	1
biantennary and triantennary N-glycans	1
TRA-1-60	1
TRA-1-81	1
laminarin	1
chitin	1
alpha2,8-disialic acids	1
α2-6Sia	1
RM2	1
mucin O-glycan core structures	1
O-linked glycoproteins	1
traumatic brain injury indicative glycan biomarkers	1
sialic acid residues in N- and O-glycans	1
N-glycan signatures	1
unique glycans	1
α-2,3-Sia	1
α-1,2-Fuc	1
α-1,6-Fuc	1
α-2,6-Sia	1
α-GalNAc	1
Gal-β-1,3-GalNAc	1
α2-3-linked N-acetylneuraminic acid	1
agalactosylated (GnGnF, GnGn(bi)F)	1
galactosylated (AGn(bi), AGn(bi)F, AA(bi), AAF)	1
monosialylated IgG glycoforms (NaAF, NaA(bi))	1
fully sialylated glycans	1
GlcNAc 6-O-sulfate	1
α2,3 and α2,6 sialyl lactosamines	1
6-O sulfated sLeX	1
di-N-acetylchitobiose	1
beta-D-glucan	1
glycan antigens	1
9-OAcSA	1
sialic acid-containing glycoproteins	1
triantennary 'complex-type' with terminal fucose	1
biantennary 'complex-type' without fucose	1
biantennary 'complex-type' with fucose	1
'high-mannose' chains	1
N-acetyl-galactosamine (GalNAc)	1
VRE-bearing glycoproteins	1
LacdiNAc-glycosylated prostate-specific antigen	1
high molecular weight glycans	1
MUC21	1
defucosylated version of humanized monoclonal antibody against HM1.24	1
core 3 sialyl-Le(x) hexasaccharide	1
T(alpha) (Galbeta1-3GalNAcalpha1-)	1
Tn (GalNAcalpha1-Ser/Thr)	1
glycated apoB	1
LDL-	1
Glycosylation at threonines 48 and 71 of human proBNP	1
glycated apolipoprotein B	1
EEQFN <sup>177</sup>STYR (H3N4)	1
EEQYN <sup>227</sup>STFR (H3N4F1)	1
A/B epitopes	1
Sialic acid-binding Ig-like lectin 8 (Siglec-8)	1
mannose-containing O-specific polysaccharides	1
blood group B trisaccharide	1
β-glucan fragment	1
(Man)(5)(GlcNAc)(2)	1
(Man)(6)(GlcNAc)(2)	1
(Hex)(4)(GlcNAc)(5)	1
tri-arabinans	1
Mac-2 binding protein glycan isomer	1
monosulfated tetra-glycosyl ceramide, SM1a, Galβ1-3GalNAcβ1-4(3-O-sulfate)Galβ1-4GlcCer	1
Fucalpha1-2Galbeta motif	1
Fucalpha1-3GlcNAc motif	1
MUC1 O-glycopeptide	1
cell surface glycan	1
glycans 1a	1
glycans 2a	1
heparin hexasaccharides	1
SLe(a)	1
α2,3-sialylated N-glycans	1
Wisteria floribunda agglutinin	1
glucuronylated T antigen	1
Le(x) glycan	1
heparins/heparan sulfates	1
sialyl N-acetyllactosamine	1
nonsialyl N-acetyllactosamine	1
glycosylated total serum proteins	1
N-glycolylated GM3	1
Tn and T glycoforms	1
agalactosylated oligosaccharides	1
hCG derivatives	1
SIRPalpha1	1
fucosylated kininogen	1
fucosylated alpha-1-antitrypsin	1
N-linked glycosylated	1
sialosyl globopentaosylceramide	1
Myelin-Oligodendrocyte Glycoprotein	1
ED-B domain	1
glycosylated molecules	1
outer arm fucose residues	1
glyco-parameters	1
AOL/DSA	1
MAL/DSA	1
GlcNAcβ	1
GA2	1
H type-1 glycan	1
GSTA	1
Galα1-3Galβ1-(3)4GlcNAc-R	1
single-N-linked glycan chain	1
anti-laminaribioside carbohydrate (ALCA)	1
anti-chitobioside carbohydrate (ACCA)	1
anti-mannobioside carbohydrate (AMCA)	1
glycan content	1
sialylated and sulphated glycans	1
fucose-containing branched trisaccharide	1
disaccharide	1
disialylated O-glycan tetrasaccharides	1
asparagine-linked glycan	1
elongated complex oligosaccharide	1
truncated O-glycans (Tn, T antigens and their sialylated forms)	1
fucosylated, non-galactosylated, non-sialylated, bisecting IgG N-glycans	1
plasma MPA and HPA binding glycans	1
multiply-galactosylated glycans and sialylated glycans, GNA-binding glycans, NPA-binding glycans, WGA-binding glycans, and bisecting GlcNAc glycans	1
N-linked complex glycans	1
sulfated sialoglycan	1
non-fucosylated triantennary sugar chain	1
glucomannan	1
Glc(alpha1,4)Glc(alpha) (GAGA4)	1
maltohexaose	1
fuco-fractions	1
tri-antennary glycan	1
core-fucosylated biantennary glycan	1
GlcNH2	1
GlcNH2/Man ratio	1
glycans terminated with galactose residues	1
LCA-binding oligosaccharides	1
blood group i epitope (linear poly-N-acetyllactosamine chain)	1
alpha(2,8)-linked disialic acid	1
α2-3 and α2-6 sialosides	1
alpha1,6-Fucose	1
GD3(d18:1/18:0)	1
GD2(d18:1/18:0)	1
tri and tetra-antennary glycan classes	1
O-GalNAc glycans	1
Tn (GalNAcα-Ser/Thr)	1
STn (Neu5Acα2-6GalNacα-Ser/Thr)	1
Le(c)Le(x)	1
di-Le(a)	1
Le(a)Le(x)	1
Le(a)-containing glycans	1
N-acetyllactosamine-type glycans	1
3-fucosyl N-acetyllactosamine	1
O-glycan processing	1
fucosylated LacdiNAc	1
glycan antigen 125 (CA125)	1
H4N3F1L1	1
H4N6F1E1	1
core and outer-arm fucosylation	1
GlcNAc(beta1,3)GalNAc	1
sialyl Lewis X epitope	1
Putative N-linked glycosylation site (PNGS) mutations	1
serum glycopatterns	1
carbohydrate antigen recognized by mAb FH6	1
core 2-based O-glycan	1
complex-type N-glycan	1
N-acetyl-neuraminic acid	1
N-glycolyl-neuraminic acid	1
core mannose oligosaccharide side chains	1
N-acetyl glucosamine-residues	1
SSEA3	1
type 1 core O-glycan	1
N-acetyllactosamine-type structures	1
oligomannoside-type structures	1
O-glucosylated (Xyl1-3Xyl1-3Glc)	1
O-fucosylated (NeuAc2-3Gal1-4GlcNAc1-3Fuc)	1
glycan chains on MUC1	1
lactosamine structures	1
O-linked glycan(s)	1
multisialylated LacdiNAc (GalNAcβ1-4GlcNAc)	1
glycosylated LRG1	1
CD20 type II epitope	1
1,6 N-acetylglucosamine (GlcNAc)	1
RAAG12	1
agalactosyl IgG	1
Thomsen-Friedenreich glycotope	1
S or Re endotoxin glycoforms	1
glycosidic conjugates of cyanidin	1
O-linked oligosaccharide chain	1
carboxylated N:-glycans	1
O-Linked oligosaccharides	1
high-mannose, hybrid and complex N-linked glycans	1
tri- and tetra-antennary fucosylated oligosaccharides	1
N-acetylhexosamine (HexNAc)	1
N-acetylglucosaminyl-phosphatidylinositol	1
MAA-reactive SA	1
SNA relative reactivity with CLU glycans	1
fucosylated structures	1
2'FL	1
LNFP I	1
LDFT	1
LNDFH I	1
tandem-repeat-type galectin-8	1
asialo GA1	1
GD3 (d18:1/24:1)	1
GD3 (d18:1/24:2)	1
core 1 O-glycan (Galbeta1-3GalNAcalpha1-Ser/Thr, T antigen)	1
sialyl-T antigen (NeuAcalpha2-3Galbeta1-3GalNAcalpha1-Ser/Thr)	1
6-sulfated glycan	1
core 3 structure of O-glycans	1
N-glycosylated asparagine	1
complex glycosylation	1
fucose-rich glycovariants	1
CML	1
CD83	1
N-linked glycosylation motifs	1
alpha-mannosyl ceramide	1
glycosylation sites (N331 and N343)	1
CD4 binding site (CD4bs)	1
sialyl Lewis X (3'SLeX)	1
glycosylated angiotensin-(1-7) peptide Ang-1-6-O-Ser-Glc-NH2 (PNA5)	1
GP 3	1
GP 8	1
GP 11	1
GP 4	1
GP 14	1
oligo mannose-rich glycoproteins	1
sialic acid-bearing glycans	1
Lewis X (Le(x))-containing glycan	1
Lewis A (Le(a))-capped glycan	1
A2G1(6)FB	1
complex type N-glycan groups	1
natural complex glycan ligand	1
fucosylated lactosaminoglycans	1
keratan sulphate	1
core3MUC1 (GlcNAcβ1-3GalNAc-MUC1)	1
STnMUC1 (NeuAcα2,6GalNAc-MUC1)	1
sialylated meningococcal lipopolysaccharide	1
bi-sialylated N-glycans	1
tri-sialylated N-glycans	1
neutral N-glycans	1
mono-sialylated glycans	1
Man(5)GlcNAc(2)	1
CA 15-3	1
tetra-antennary N-glycans	1
tri-antennary N-glycans	1
Neu5Ac-α2, 6-Gal-β1, 4-GlcNAc-β1, 4-GlcNAc	1
O-Glycans	1
N-acetyl galactosamine/galactose (GalNAc/Gal)-associated glycan	1
α2,3-sialylated prostate-specific antigen (S23PSA)	1
Siglec-9 sialoglycan ligands	1
Galβ1,3GalNAc	1
sialic acid-binding immunoglobulin-like lectin 8	1
fPSA glycosylation	1
galectin-7	1
sialyl-Tn (Neu5Acalpha2-6-GalNAc)	1
Lewis(x) trisaccharide	1
MUC1-glycopeptides	1
GM1-like	1
GT1a-like	1
GD3-like	1
GD1a-like	1
Gal: Man: GlcN: GaIN	1
tetrasaccharide O-glycans	1
hexasaccharide O-glycans	1
N-linked glycan epitopes	1
N- and O-glycosylated sugar chains	1
H-type3	1
cancerous glycans	1
glycan-phosphatidylinositol	1
alginate	1
sialyl Lewis X (sLe<x>)	1
sialyl Lewis A (sLe<a>)	1
Mac-2-binding protein glycan isomer	1
glycan part of PSA	1
sialyl Lewis a (sLea)	1
N-glycan modification	1
m/z 1201	1
m/z 1449	1
glycosylated MUC1 tumor antigen	1
V3 region	1
gp41 amino terminus	1
underglycosylated forms of LGR5	1
glycosylated forms of alpha-dystroglycan	1
sialylated glycan isomers	1
specific glycan patterns	1
branched core 2 structures	1
linear core 1 or core 3 structures	1
MHC associated glycan	1
blood group	1
N-glycosylated forms	1
glycosylated NIS	1
heavily glycosylated core and loop structures	1
glycosylated versions of the HIV proteins	1
nonglycosylated versions of the HIV proteins	1
C-glycosyltryptophan	1
3-carboxy-4-methyl-5-propyl-2-furanpropanoate	1
glycan ligand of the inhibitory receptor CD33 (CD33L)	1
Glc(alpha1,4)Glc(alpha)	1
6'-sulfo-sLe(x)	1
high mannose-type N-glycan biosynthesis	1
Sialyl Lewis a	1
Glc2NTs	1
O-linked sialyloligosaccharides	1
Ca 19-9	1
Ca 50	1
T(N) antigen	1
Glycosylphosphatidylinositol	1
C2-O-sLe(x)	1
Desialotransferrin	1
glycan chains	1
α2-6 sialylation on N-glycans	1
ABO glycan	1
GalNAcalpha1-Ser/Thr (Tn)	1
α-N-acetylgalactosamine (GalNAc)	1
α-N-acetylglucosamine (GlcNAc)	1
dp5	1
F1 alpha (Gal beta 1-->4GlcNAc beta 1-->6GalNAc alpha 1-->Ser/Thr)	1
Fucα1-2Galβ1-3GalNAc-R	1
βGal-βGalNAc residues	1
HPA and PNA binding glycostructures	1
Tn and sialyl-Tn (sTn) O-glycans	1
altered glycosylation of MUC1	1
prothrombin A2G2S	1
immunoglobulin J chain FA2G2S2	1
clusterin A2G2	1
complement component C8A A2G2S2	1
apolipoprotein M glycopeptide with non-fucosylated and non-sialylated hybrid-type glycan	1
d-GM3	1
d-GD3	1
O126 glycoforms	1
BGP I	1
3-sulfoglucuronyl beta1-3 galactoside	1
human natural killer cell antigen-1 (m-HNK)	1
N260 glycan	1
sialyl Lewis x in core 2 branched O-glycans	1
sialyl Lewis x in extended core 1 O-glycans	1
Fc gamma RIIIb	1
Fc gamma RIIa	1
monosialylated, core 2-based O-glycan with a sialyl Lewis x (C2-O-sLe(x)) motif	1
high mannose tri and tetra antennary N-glycans	1
Tn-antigen (GalNAcα-Ser/Thr)	1
sialylated core 1 (sialyl-T, ST) oligosaccharides	1
O-secretor mucin glycan phenotype	1
N-linked glycosylation site (N66)	1
D1 domain glycan	1
difucosylated oligosaccharide Lewis Y (Le(Y))	1
Peak9	1
Peak9p	1
Peak12	1
Peak11	1
sialylated PFPL O-glycans	1
galectin-3-reactive glycoligands	1
non-glycosylated NT-proBNP	1
complex-type N-linked glycans having multivalent GlcNAc termini	1
penta-antennary complex-type with bisecting GlcNAc	1
bi-antennary complex-type	1
multi-antennary complex-type N-linked OS	1
xylose-binding proteins	1
sialylated Lewis(x) sequence	1
Gal3Sulfo-T(2)	1
Gal3Sulfo-T(4)	1
GlcNAc6Sulfo-T	1
alpha1,2-fucosyltransferase	1
sialylated antigens	1
Galβ1-3GalNAc	1
(β-GlcNAc)n	1
bi- and triantennary N-glycan containing Galβ1-4GlcNAcβ1-2Manα1-6	1
terminal Galβ1-4GlcNAc	1
glycolipids	1
(2,3)-sialyl-T antigen	1
NeuAc alpha 2-6Gal	1
core N-glycans	1
alpha-linked mannose	1
mannose-rich polypeptide	1
complex carbohydrate group	1
glycosylation motif (NTT (221-223))	1
O-glycan core 1 structure	1
glycan phosphoinositol (GPI) anchor	1
NeuGc alpha 2-6Gal beta 1-4GlcNAc	1
Wisteria floribunda agglutinin-positive Mac-2 binding protein	1
TF antigen	1
9-N-(2-naphthyl-sulfonyl)-Neu5Acα2-3-[6-O-sulfo]-Galβ1-4GlcNAc	1
N276	1
N460/N463	1
Lewis(x) (Le(x))	1
glycan structures of fetuin	1
fucose-containing glycans	1
CD4-binding site	1
globotriaosylceramide (Gb3)	1
α(2,6)-linked sialylation	1
Hexuronic Acids	1
phosphatidyl-inositol-glycan	1
altered carbohydrate moieties	1
MUC-1 polypeptide	1
Glycosyl-phosphatidylinositol (GPI) anchor	1
high mannose glycan	1
STn antigen	1
alpha-dystroglycan	1
asialylated LDL	1
glycosylated on asparagine residues	1
1-aminoglucosesuccinate	1
bisecting N-acetylglucosamine (GlcNAc) residues	1
core-glycosylated	1
(Galbeta)Ser	1
(Glcalpha,beta)Tyr	1
branched oligosaccharides	1
galactose-specific lectins	1
Neu5Acα2-3[6S]Galβ1-4GlcNAc	1
N- or O-glycans	1
Thomsen-Friedenreich (T, Gal beta 1-->3-GalNAc alpha 1-->Ser/Thr)	1
mucin O-glycan	1
Concanavalin A-non-reactive fraction	1
STF	1
alpha(1-2)fucosylated glycans	1
stage-specific embryonic antigen-4 (SSEA-4)	1
blood group A trisaccharide	1
Sig8L	1
fucosylated core 1 O-glycan	1
fucosylated forms	1
asialo-AGP	1
defined cell surface glycans	1
core 1 O-glycan structure, Gal-GalNAc-O-Ser/Thr	1
mucin type-O-glycans	1
P63	1
neutral and acidic carbohydrates	1
aspartylglycosamine	1
T/Tn antigen	1
CA199	1
CD33	1
glycan vibrations	1
Gal(beta1-O)Thr	1
Gal(beta1-S)Cys	1
Gal(beta1-N)Asn	1
Lac(beta1-O)Thr	1
Sialyl-Lewis(x)	1
sialo-N- and O-glycans	1
STn glycoform	1
sialylated MUC4β N-glycans	1
multifucosylated sequence	1
multi-antennary sialylated N-glycolylneuraminic acid (Neu5Gc)	1
phosphatidylinositol glycan (PIG)	1
blood group H type 2 (BG-H)	1
Lewis-x (Le(x))	1
β-glycan	1
Neu5Acalpha2-3Galbeta1-4Glc	1
glycosylated parasitic structure	1
disialosyl globopentaosylceramide (DSGb5 (d18:1/16:0))	1
N-linked glycan chain	1
Thomsen nouveau (Tn) antigen	1
high-branched N-glycans	1
ABO blood group glycan antigens	1
P(1)	1
N276_gp120 glycan	1
glycan276	1
aberrantly glycosylated IgA1	1
glycan cap	1
disialotetrasaccharides NeuNAc alpha 2----3Gal beta 1----3(NeuNAc alpha 2----6)Gal-NAc-Ser/Thr	1
NeuNAc alpha 2----3Gal beta 1----3(NeuNAc alpha 2----3Gal beta 1----4GlcNAc beta 1----6)GalNAc-Ser/Thr	1
alpha-galactose	1
H epitope	1
Fucosylated multi-antennary glycopeptide markers	1
glycosylated precursors	1
Fucalpha1-->2Fucalpha1-->3[Gal(NAc)beta1-->4]GlcNAc	1
N-glycan monosaccharide compositions	1
H antigen	1
abnormally glycosylated hCG	1
Laminin-511	1
N-Acetyllactosamine	1
V3 loop	1
fucosylated leukocyte PSGL-1	1
O-linked, sialated glycan	1
oligomannose type N-linked glycans	1
mannosyl core of complex type N-linked glycans	1
MALDI-TOF MS peaks	1
CA199.STRA	1
6-sulfated galactose	1
N-linked glycan at position-276	1
Lewis x determinant (Le(x))	1
β-1,6-N-acetylglucosamine moiety of N-linked glycan	1
glycan chain	1
sialyl-T(N)	1
alpha2,6-sialyl-T	1
alpha2,3-sialyl-T	1
Siaalpha2-3Galbeta1-4GlcNAc	1
Core 1 glycan, Galβ1-3GalNAc	1
Gal beta 1,3GalNAc-PA	1
NeuAc alpha 2,3Gal beta 1,3(NeuAc alpha 2,6)GalNAc-PA	1
NeuAc alpha 2,3Gal beta 1,3GalNAc-PA	1
Sialyl-Lewis X (SLe(x))	1
Galβ1-3GlcNAcβ	1
V2 loop glycosylation	1
de-N-acetyl polysialic acid (dPSA)	1
α-L-fucose	1
α-(2,6)-linked terminal sialic acid	1
α-(2,3)-linked terminal sialic acid	1
antibody Fc-glycosylation	1
β1,6GlcNAc-branched N-glycans	1
galectin‑based magnetic glycan recognition particles	1
sialic acid linked α 2-3	1
sialic acid linked α 2-6	1
sialyl Lewisx	1
N,N-diacetyllactosamine (LacdiNAc)	1
Tn (GalNAcalpha(1-1)-Thr/Ser)	1
T (Galbeta(1-3)-GalNAcalpha(1-1)Thr/Ser)	1
Fc domain glycan	1
Lewis B	1
glycan phosphatidyl inositol-anchored Fc gamma RIII-1	1
mannosylated and fucosylated structures	1
beta 1-6-branched N-linked oligosaccharides	1
GalNAc (Tn-antigen)	1
Galβ1-3GalNAc (T-antigen)	1
NeuAcα2-3Galβ1-3GalNAc (sialyl-T-antigen)	1
NeuAcα2-6GalNAc (sialyl-Tn-antigen)	1
O-sialoglycans	1
beta glycan	1
Sialyl-Tn antigen (SAalpha2-6 GalNAc alpha-Ser/Thr)	1
disialylated core fucosylated biantennary structures with α2,6-SA	1
sialylated diantennary and hybrid-type glycans	1
alpha2,6 sialylation	1
alpha2,3 sialylation	1
mannose-related N-glycans	1
fucose-related sequences	1
Lewisx-related sequence	1
dextran	1
GlcNAc(beta 1-6)GalNAc(alpha 1-OBn) (core 6-Bn)	1
N-acetyl galactosaminylated glycans	1
N230 glycan	1
disialyl-T	1
glycan core of the LPG GPI anchor	1
Agaricus bisporus (ABA) lectin	1
Thomsen-Friedenreich (T) glycotope	1
Gb(4)Cer	1
Lc(4)Cer	1
fucosyl Lc(4)Cer	1
disialyl Gb(5)Cer	1
O-linked oligosaccharide chains	1
b1-6 branched glycan structures	1
trimeric Tn antigen (tTn)	1
glycosylated polypeptide chain	1
phosphatidylinositol glycan moiety	1
Lewis Y (Le<sup>Y</sup>)	1
ketodeoxynonulosonic acid (Kdn)	1
human blood group A-determinant structure	1
sLe(x) gangliosides with terminal Neu5Acα2-3Galβ1-4(Fucα1-3)GlcNAc epitope	1
type 1 chain (Gal beta 1-3GlcNAc beta 1-)	1
PrPC	1
Sia-containing glycan epitope	1
fucosylated oligosaccharide	1
P-selectin glycan ligands	1
6-sulfo-sialyl-Lewis(x)	1
fully sialylated biantennary glycans	1
glycan phosphatidylinositol-linked	1
alpha-NeuAc-(2----3)-beta-D-Gal	1
hexose	1
hexosamine	1
glycan at N386	1
GlcA-GlcNH3+	1
Galectin-3	1
β-D-1,3-glucan	1
glycosylphosphatidylinositol moiety	1
neolacto-series GSLs (SSEA-1 and H type 2 antigen)	1
complex N-glycans encompassing β1,2 xylose and α1,3 fucose glycoepitopes	1
concanavalin A nonreactive fraction	1
concanavalin A weakly reactive fraction	1
sialyl-Lewisx (Si-Lex)	1
core 6-related epitope on core mucin glycans	1
Mucin type O-glycan	1
O-linked sialylated keratan sulfate chains	1
GalNAcbeta1-4(Fucalpha1-3)GlcNAc	1
phosphatidylinositol	1
glycosylated in the light chain variable region	1
glycosylated recombinant form of human IL-6	1
biantennary N-linked glycans	1
GalNAcalpha1-->Ser/Thr (Tn)	1
Galbeta1-->3GalNAcalpha1-->Ser/Thr (T(alpha))	1
Lewis-x	1
Thomsen-Friedenreich (Tf) antigen	1
Sialyl Thomsen-nouveau (STn) antigen	1
Sialic Acid Binding Immunoglobulin-like Lectins	1
O-glycan biosynthesis	1
sialylated core 1 type O-glycans	1
glycan structure	1
phosphatidylinositol glycan (PI-G) anchor	1
α2,3-linked N-sialyllactose polymer	1
N-acetylneuraminic acid	1
glycosylated antigens	1
lambda-carrageenan	1
DUPAN-2	1
mucin O-glycosylation	1
haptoglobin bifucosylated tetra-antennary glycan	1
mannosylated structures	1
6-sulfo LacNAc	1
sialomucin	1
LCA-binding AFP	1
O-GalNAcylation	1
Asialoglycoproteins	1
hyposialylated CD43	1
N463	1
mucin core peptide (MUC) 2	1
MUC3	1
TFF3	1
asparagine-linked carbohydrates	1
high-affinity glycan ligand	1
3'-sialyl-N-acetyllactosamine	1
6'-sialyl-N-acetyllactosamine	1
sialyllacto-N-tetraose b	1
N-Glycan biosynthesis	1
alpha 2-->8-linked disialylated poly-N-acetyllactosamine	1
glycosylphosphatidylinositol (GPI) glycan	1
GalNAcalpha1-O-Ser/Thr (Tn)	1
NeuAcalpha2-6GalNAcalpha1-O-Ser/Thr (STn)	1
sulphated glycans	1
LeX	1
473HD	1
sialyl Lewis X (SLeX)	1
α 2,6-linked tri-sialylated triantennary glycan containing α1,3-linked fucose	1
glycan-containing surfaces	1
phosphatidyl inositol glycan (PIG)	1
HBGAs	1
N-Acetylneuraminic Acid (Neu5Ac)	1
oligomannose type glycosylation	1
teichoic acid	1
Galβ1-3GlcNAc	1
bisecting glucosaminylated biantennary	1
sulfated sialyl Lewis x	1
lactosamine	1
Asn-linked glycans	1
3-sialyl di-Lewis x	1
mono- and difucosylated forms of the disaccharide lactose	1
Lewis(x) and/or Lewis(y) epitopes	1
(GlcNAcbeta1-3/4Glc)	1
type 2 (Galbeta1-4GlcNAc)	1
serotransferrin glycoforms	1
glycan part of the 22C3 epitope	1
α-2,6 linked SA	1
phosphatidyl-inositol-glycan-anchored glycoprotein	1
phosphatidylinositol glycan anchored protein (PIG-AP)	1
mannose-binding lectins	1
beta(1,6)-branched N-linked glycan structures	1
L-PHA reactive glycoproteins	1
unsialylated N-linked glycans	1
laminaribioside	1
chitobioside	1
Manβ1-4GlcNAcβ	1
n-butyrate- and acetate-modified ManNAc analogues	1
nonsulfated HNK-1 epitope	1
di-N-acetylchitobiosyl	1
type 1 and 11 ABH blood group epitopes	1
Galactosamine	1
blood group A tetrasaccharide type II	1
BgA trisaccharide	1
glycan microheterogeneity	1
sialyl-fucosylated core 2 O-glycan (CHO-131 antigen)	1
sulfated Lewis X determinants	1
Sialyl Lewis x (sLe(x))	1
Sialyl Lewis a (sLe(a))	1
sialooligosaccharide sequences	1
GD3 ganglioside	1
Lewis y antigen	1
Forssman determinant	1
asparagine-linked sugar chain	1
glycan portion of the GPI anchor	1
sialyl-Lewisa/x (sLea/sLex)	1
N-acetyl glycan groups	1
LacCer (d18:1-h23:0)	1
N-glycan moieties	1
proinflammatory IgG glycans	1
terminal alpha- and beta-linked GalNAc residues	1
6-sulfo sialyl Lewis(x)	1
O-linked oligosaccharide	1
myo-inositol	1
D-chiro inositol	1
mannan epitope of Saccharomyces cerevisiae (gASCA)	1
laminaribioside (ALCA)	1
chitobioside (ACCA)	1
mannobioside (AMCA)	1
outer membrane porins (Omp)	1
branched hexasaccharides, NeuNAc alpha 2----3Gal beta 1----3(NeuNAc alpha 2----3Gal beta 1----4GlcNAc beta 1----6)GalNAc	1
tetrasaccharides NeuNAc alpha 2----3Gal beta 1----3(NeuNAc alpha 2----6)GalNAc	1
Tn antigen (GalNAcα-Ser/Thr)	1
IgG hypogalactosylation	1
decreased galactosylation of IgG	1
O-glycan-peptide signatures	1
core 2-containing O-glycans	1
T-antigen (Galbeta1-3GalNAc-Thr/Ser)	1
type I and II ABH blood group epitopes	1
sialylated Hp	1
fucosylated Hp	1
Hp	1
glycans in CA125	1
arabinoxylan	1
glycosyl-PI (GPI) anchor	1
anti-disialosyl galactosyl globoside	1
anti-fucosyl GM1	1
anti-Gb2	1
asialo-lactosamine	1
glycan epitope on CD52g	1
beta-D-GalpNAc-(1-->4)[alpha-L-Fucp-(1-->3)]-beta-D-GlcpNAc	1
Tn glycotope	1
Ga1NAc	1
O-linked monosaccharide glycans	1
high-molecular-weight glycosylated exoprotein	1
N-linked glycosylation pattern	1
lacdiNAc sequence GalNAc beta 1-->4GlcNAc beta 1-R	1
β1,6 GlcNAc (N-acetylglucosamine) branches	1
Galbeta1-3GlcNAc	1
incompletely sialylated N-linked glycans	1
core I O-glycans	1
monosialyl T antigen	1
disialyl T antigen	1
90K	1
mucin-type O-glycan biosynthesis	1
O-Acetyl-GD2	1
N362 glycan	1
N463 glycan	1
Tn antigen (GalNAcalpha-O-Ser/Thr)	1
high mannose type	1
complex type	1
sialofucosylated structures	1
lipoarabinomannan	1
Ulex Europaeus Agglutinin I (UEA-I)	1
glycosphingolipid	1
core 1 O-glycans (Gal beta 1-3GalNAc alpha 1-Ser/Thr)	1
high-mannose and hybrid glycoforms	1
mannose-5 or mannose-6 glycoform	1
hybrid glycoform	1
Man3-GlcN-inositol	1
high-mannose-type sugars	1
Fucosylated glycans, including H-antigen	1
O-glycan core 2 structure [Gal beta 1-3(GlcNAc beta 1-6)GalNAc]	1
SSEA-1	1
sialyl Lewis X (sLe<sup>x</sup>)	1
mannan epitope of S. cerevisiae	1
gASCA	1
ALCA	1
AMCA	1
biantennary disialylated N-glycan completed with two Neu5Acalpha2-3 residues	1
GM4 sialylated glycolipid Neu5Acalpha2-3Galbeta1-Cer	1
1,7 intramolecular lactone of N-acetyl-neuraminic acid	1
N-linked and O-linked HNK-1-like epitopes	1
HIV-specific Fc-glycans	1
cell surface glycans	1
alpha 2-6-linked Sias	1
phosphoinositol (PI) glycan moiety	1
alpha2beta1 integrin	1
glycan at N160	1
glycan at N276	1
alpha 2,6-linked sialic acid	1
alpha1,4-GlcNAc-capped O-glycans	1
α2,3-NeuAc-containing glycoproteins	1
PD-L1	1
T-Antigen (Gal-beta1,3-GalNAc-alpha-O-Ser/Thr)	1
fucosylated lactosamines	1
complex hybrid glycans	1
Gal4,4,4TRI	1
Gal4,4,3TRI	1
fucosyl biantennary complex type structure	1
nonfucosylated biantennary structure	1
ABH blood group epitopes	1
high mannose-type glycans	1
glycan in the Fc domain of tmab	1
O-linked N-acetylgalactosamine	1
GalNAc beta(1-4)[Fuc alpha(1-3)]GlcNAc beta-OMe	1
IgA1 N-linked and O-linked glycans	1
chondroitin-4 sulfate	1
sulfated blood group chains	1
N-linked high mannose type	1
GlcNAcalpha1-->4Galbeta-->R	1
N-glycan at Asn297	1
branched N-glycan	1
phosphatidylinositol-glycan-linked Fc gamma RIII	1
N-linked high mannose glycans	1
PIGL	1
glycans attached to both Cbeta and Calpha domains	1
3'-sialyl-6-sulfo Lewis a	1
Siaα2-6Gal/GalNAc-binding lectins	1
glycans and glycosaminoglycans	1
3'-sulpho-Le(x)	1
3'-sulpho-Le(a)	1
polylactosamine glycans	1
α2,6-sialylated glycoconjugates	1
triantennary N-linked oligosaccharides	1
alpha 1-6-fucosylation of the asparagine-bound GlcNAc	1
Neu5Ac alpha 2-3Gal beta 1-3(Neu5Ac alpha 2-6)GalNAc-ol	1
Neu5Ac alpha 2-3Gal beta 1-4GlcNAc beta 1-6(Neu5Ac alpha 2-3Gal beta 1-3)GalNAc-ol	1
Thy-1	1
sialyl Lewis b	1
α2-Heremans-Schmid Glycoprotein (AHSG/fetuin A)	1
Galectin-8	1
Lewisx (Lex)	1
Neu5Gcα2-6GalNAcα1-O-Ser/Thr (GcSTn)	1
galactose-terminal glycans	1
O-linked and complex N-linked glycans	1
mannosyl	1
N-acetylglucosaminyl	1
WFA(+)-CSF1R	1
abnormally glycosylated IgA1	1
decreased sialylation of IgA1	1
galactose deficiency	1
abnormally glycosylated polymeric IgA1	1
soluble CD89-IgA and IgA-IgG complexes	1
glycan phosphoinositol anchor	1
N-linked glycan branching	1
phosphatidylinositol glycan-linked form of FcRIII	1
sialyltransferase ST6GAL1	1
phosphatidylinositol glycan-class A	1
bulky glycocalyx	1
complex type biantennary oligosaccharides	1
sialo biantennary oligosaccharides	1
complex type triantennary oligosaccharides	1
sialic acid (SIA)	1
mannose-rich glycans	1
sialylated Siglec-F ligands	1
CD52 N-linked glycan, in α-2,3 sialic acid linkage with galactose	1
β-(1-4)-galactose	1
O- and N-glycan chains	1
beta-galactosyl-beta-N-acetylglucosamine-galactosaminitol (sialic acid)	1
beta-galactose-beta-N-acetylglucosamine-galactosaminitol	1
beta-galactose-galactosaminitol	1
N-glycan residue	1
galactosylated IgG Fc N-linked glycans	1
sialylated IgG Fc N-linked glycans	1
bisecting N-acetylglucosamine-containing IgG Fc N-linked glycans	1
IgG glycan	1
N-Acetyl galactosamine residues	1
chondroitin type glycosaminoglycans	1
core-2-branched O-linked glycans	1
high mannose and/or hybrid-type N-glycans	1
sialyl T antigen (Neu5Acα2,3Galβ1,3GalNAcα1→)	1
Sialyl-Thomsen-nouveau antigen (STn)	1
Asn-linked oligosaccharide chains	1
α2,3-sialylated glycans	1
Galbeta1-4(Fucalpha1-3)GlcNAc (Lewis(x))	1
GalNAcbeta1-4GlcNAc (LDN)	1
3'-Sulfo-Lewis A/C	1
CSF114(Glc)	1
keto-galactose	1
Wisteria floribunda agglutinin-positive Mac-2 binding protein glycan isomer (M2BPGi)	1
CT glycans	1
A2G2F	1
alpha2,6-linked sialic acid-bearing glycans	1
Mucin core-2 structure Galbeta1,4GlcNAcbeta1,6(3-O-MeGalbeta1,3)GalNAcalpha-O-Bn	1
Globo H precursor (Galbeta1,3GalNAcbeta1,3Galalpha-O-Me)	1
Galbeta1,4(6-O-sulfo)-GlcNAcbeta-O-Al	1
Galbeta1,3(6-O-sulfo)GlcNAcbeta-O-Al	1
core 2 N-acetylglucosamine	1
α-2,6-sialic acid	1
carbohydrate at position 386	1
N160 glycan-V1/V2 site	1
glycan backbone of peptidoglycan	1
GPI anchor	1
sulphation of glycans	1
Thomsen-Friedenreich (TFα) antigen	1
Core2 β1,6-N-acetylglucosaminyltransferase	1
high-mannose Glycans	1
Glycosylphosphatidylinositols	1
core glycan	1
sialyl-Lewis(x) motif	1
O:-linked glycans	1
terminal alpha1,4-GlcNAc	1
hyaluronic acid	1
Sialyl Lewis X (SLe(x))	1
sialylated and fucosylated oligosaccharide	1
GT1 (d18:1/20:0)	1
O-Ac-GD2	1
O-Ac-GM4	1
anti-GP2	1
Sialic acid-binding immunoglobulin-like lectin (Siglec)-8	1
glycans of the spike	1
6-sulfo sialyl Lewis x (sLe(x))	1
2-linked fucosylated glycans	1
1,3,4-O-acetyl-N-azidoacetylmannosamine (Ac3ManNAz)	1
l-rhamnose (Rha)	1
sialylated/fucosylated glycans	1
ACE2	1
sialylglycans	1
α2,3- and α2,6-linked residues of glycoconjugates	1
gASCA (anti-Saccharomyces cerevisiae) IgG	1
gASCA IgA	1
anti-chitobioside (GlcNAc(beta1,4)GlcNAc(beta))	1
anti-laminaribioside (Glc(beta1,3)Glb(beta))	1
anti-mannobioside (Man(alpha1,3)Man(alpha))	1
oligomannosidic structures	1
Thomsen-Friedenreich TACA disaccharide	1
NPL lectin	1
PNA lectin	1
LCA lectin	1
WGA lectin	1
Lewis O-chain	1
heptoglycan domain	1
glucosylated Lewis O-chains	1
elongated PS composed of alternating 2-, and 3-monosubstituted alpha-D-Glcp residues	1
Thomsen-Friedenreich (TF; Galβ1,3GalNAcα-)	1
Glycosylphosphatidylinositol (GPI) anchor	1
N-glycan precursors	1
fibrillar extracellular matrix of glycans	1
α1,3-fucosylated glycans	1
Thomsen-nouveau-polysaccharide A1 (Tn-PS A1)	1
sialosyl Lewis(a)	1
glucuronic acid 3-sulfate	1
Sialyl-Lewis X (Slex)	1
V3 glycan-dependent	1
highly fucosylated high m.w. type 1 Lewis glycans	1
ABH group epitopes	1
keratan sulfate	1
sialylated N-linked glycans	1
C80 glucose-6-monomycolate	1
sialylated, fucosylated lactosaminoglycans	1
N-acetylgalactosamine beta-1 (GalNAcβ1)	1
alpha-2,3-linked sialic acid	1
HLA-G	1
carrageenan	1
alginic acids	1
C2-O-sLex	1
sialyl Lewis X (sLe(X)) antigen	1
α-galactopyranosyl (α-Gal) epitopes	1
β1,6GlcNAc-branched N-linked glycans	1
fucosylated LacdiNAc (LDN-F)	1
sialofucosylated glycoprotein(s)	1
β-D-glycan	1
biantennary heavy chain glycans	1
fucosylated biantennary N-linked structures	1
biantennary N-linked structures	1
monoantennary oligosaccharide	1
triantennary oligosaccharide	1
sialosides	1
glycosyl phosphatidylinositol (GPI)-anchored proteins	1
sialyl-Lewis x (sLe(x))	1
Le glycans	1
non-terminal carbohydrate in the mucin O-glycans	1
glycosylated form of EDN	1
V2-glycan	1
CD4-binding-site	1
glycan-dependent epitopes	1
conserved nonlinear epitope in the V3 region	1
CD4BS epitope	1
Lewis x (Lex)	1
S121 epitope	1
alpha-GalNAc	1
Tn epitope	1
blood group A antigen	1
sialyl-Lewis(X)	1
sulfatide	1
sulfoglucuronyl glycolipids	1
Galbeta1,4(Fucalpha1,3)GlcNAc (Lex)	1
Lea	1
Leb	1
Ley	1
V1V2 glycan	1
membrane-proximal glycan	1
CD4 binding site glycan	1
sialyl-Lewis(a) (sLe(a))	1
histo-blood group A trisaccharide	1
sialyl-Lewis X/A (sLeX/A)	1
core 2 branching structure	1
GalNAc-containing oligosaccharides	1
mannosylated lipoarabinomannan	1
N-acetylhexosamine-sialic acid	1
sialyl-Lewis(x) tetrasaccharide	1
N-linked glycan-dependent epitope	1
glycans located in the V1/V2, V3 and V4 regions	1
alpha 3-galactosyl-capped trisaccharide	1
beta 4-galactosyl-capped trisaccharide	1
glycan-dependent HIV-1 bNAbs	1
mannosyl/N-acetylglucosaminyl derivatives	1
Gal-GalNAc	1
6-sulfo N-acetyllactosamine/Lewis x	1
mannose-terminating glycans	1
V1V2 glycan site	1
sialyl Lewis x-containing glycan	1
Tn antigen (GalNAc-α-O-Ser/Thr)	1
glycan-dependent monoclonal antibody epitopes	1
tRNA-Val	1
N-linked glycan profile	1
selectin ligand	1
glycan biosynthesis and metabolism	1
V1V2 glycan-dependent epitopes	1
blood group ABO antigens	1
Lewis-type epitopes	1
fucose containing structures	1
sialyl-LeA (SLeA)	1
galectin-9	1
alpha-L-fucose	1
N-acetylneuraminyl, alpha- and beta-galactosyl, and N-acetylhexosaminyl sugars	1
6-sulfo sialyl Lewis X-capped O-glycans	1
anti-chitobioside carbohydrate antibodies (ACCA)	1
anti-laminaribioside carbohydrate antibodies (ALCA)	1
anti-mannobioside carbohydrate antibodies (AMCA)	1
pANCA	1
heavy-chain glycans	1
O-glycan branching	1
Man5-enriched N-glycans	1
glycan or glycopeptide epitope	1
glycoform of Dermatophagoides pteronyssinus group 7 allergen (Der p 7)	1
lacto-N-fucopentaose III	1
